Osteoarthritis: Epidemiology, Diagnosis, and Treatment

Abstract

Osteoarthritis (OA) is a highly prevalent, heterogeneous whole-joint disorder that represents a leading cause of chronic pain, physical disability, and socioeconomic burden globally. It has emerged as a major public health challenge affecting millions of individuals. The pathogenesis of OA involves joint degeneration, biomechanical stress, systemic inflammation, metabolic disorder, subchondral bone remodeling, and cartilage matrix imbalance. Conventional diagnostic approaches fail to identify early-stage pathological changes, while current clinical interventions primarily offer symptomatic relief with limited disease-modifying efficacy. However, effective early biomarkers, clear stratification mechanisms, and precision targeted therapies for OA remain largely insufficient. Therefore, it is particularly imperative to elucidate the advances in the pathophysiological mechanisms of OA and explore novel biomarkers as well as targeted therapeutic strategies. This review systematically updates the latest epidemiological features of OA, assesses imaging and fluid-derived biomarkers for early and accurate diagnosis, and reorganizes evidence-based pharmacological, nonpharmacological, interventional, surgical, and emerging therapies. By clarifying the key pathophysiological characteristics of OA and conducting an in-depth analysis of current diagnostic and therapeutic strategies, this review establishes a theoretical foundation for OA precision medicine, effectively accelerates the clinical translation of novel biomarkers and targeted therapies, and ultimately alleviates the global socioeconomic and disease burden attributable to OA.

Keywords

biomarker / imaging marker / osteoarthritis / treatment

References

[1] S. Tang, C. Zhang, W. M. Oo, et al., “Osteoarthritis,” Nature Reviews Disease Primers 1 (2025): 10.

[2] Y. Fei, X. Li, Z. Lv, et al., “Promoting Chondrogenesis by Targeted Delivery to the Degenerating Cartilage in Early Treatment of Osteoarthritis,” Bioactive Materials 40 (2024): 624–633.

[3] N. Angrisani, C. von der Ahe, R. Willumeit-Romer, et al., “Treatment of Osteoarthritis by Implantation of Mg- and WE43-cylinders—A Preclinical Study on Bone and Cartilage Changes and Their Influence on Pain Sensation in Rabbits,” Bioactive Materials 40 (2024): 366–377.

[4] S. P. Messier, D. P. Beavers, K. Queen, et al., “Effect of Diet and Exercise on Knee Pain in Patients with Osteoarthritis and Overweight or Obesity: A Randomized Clinical Trial,” Jama 22 (2022): 2242–2251.

[5] R. Caya, R. M. Christopherson, A. Pierobon, et al., “Does Mental Health Mediate the Effect of Nonsurgical Exposures on Pain and Functional Outcomes in Osteoarthritis? A Systematic Review,” Osteoarthritis and Cartilage (2026).

[6] V. Kuan, S. Denaxas, P. Patalay, et al., “Identifying and Visualising Multimorbidity and Comorbidity Patterns in Patients in the English National Health Service: A Population-based Study,” Lancet Digit Health 1 (2023): e16–e27.

[7] M. Kloppenburg, M. Namane, and F. Cicuttini, “Osteoarthritis,” Lancet 10472 (2025): 71–85.

[8] C. Bartholdy, A. Dossing, Z. R. Stisen, et al., “Effect of Heated Mittens on Physical Hand Function in People With Hand Osteoarthritis: Randomised Controlled Trial,” Bmj 387 (2024): e078222.

[9] H. Bliddal, H. Bays, S. Czernichow, et al., “Once-Weekly Semaglutide in Persons With Obesity and Knee Osteoarthritis,” New England Journal of Medicine 17 (2024): 1573–1583.

[10] J. N. Katz, K. R. Arant, and R. F. Loeser, “Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review,” Jama 6 (2021): 568–578.

[11] Q. Dang, Z. Hong, D. Zeng, et al., “MRI-based Radiomics to Determine the Role of Thigh Muscle Quality in the Development of Knee Osteoarthritis: A Discovery and Validation Study,” Journal of Advanced Research 79 (2025): 819–831.

[12] T. G. Wilson, M. Baghel, N. Kaur, et al., “Circulating miR-126-3p Is a Mechanistic Biomarker for Knee Osteoarthritis,” Nature Communications 1 (2025): 2021.

[13] N. R. Fuggle, R. Chapurlat, A. Laslop, et al., “Novel Approaches to the Stratified Management of Knee Osteoarthritis,” Nature Reviews Rheumatology 11 (2025): 684–695.

[14] A. Latourte, M. Kloppenburg, and P. Richette, “Emerging Pharmaceutical Therapies for Osteoarthritis,” Nature Reviews Rheumatology 12 (2020): 673–688.

[15] A. Dell'Isola, F. Recenti, B. Giardulli, et al., “Osteoarthritis Year in Review 2025: Epidemiology and Therapy,” Osteoarthritis and Cartilage 11 (2025): 1300–1306.

[16] G. A. Hawker and L. K. King, “The Burden of Osteoarthritis in Older Adults,” Clinics in Geriatric Medicine 2 (2022): 181–192.

[17] V. P. Leifer, J. N. Katz, and E. Losina, “The Burden of OA-health Services and Economics,” Osteoarthritis and Cartilage 1 (2022): 10–16.

[18] GBD 2021 Osteoarthritis Collaborators. “Global, Regional, and National Burden of Osteoarthritis, 1990–2020 and Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021,” The Lancet Rheumatology 9 (2023): e508–e522.

[19] X. X. Li, F. Cao, C. N. Zhao, et al., “Global Burden of Osteoarthritis: Prevalence and Temporal Trends From 1990 to 2019,” International Journal of Rheumatic Diseases 8 (2024): e15285.

[20] C. G. Boer, K. Hatzikotoulas, L. Southam, et al., “Deciphering Osteoarthritis Genetics Across 826,690 Individuals From 9 Populations,” Cell 18 (2021): 4784–4818.e4717.

[21] N. A. Segal, J. M. Nilges, and W. M. Oo, “Sex Differences in Osteoarthritis Prevalence, Pain Perception, Physical Function and Therapeutics,” Osteoarthritis and Cartilage 9 (2024): 1045–1053.

[22] Y. S. Yan, Z. Qu, D. Q. Yu, et al., “Sex Steroids and Osteoarthritis: A Mendelian Randomization Study,” Frontiers in Endocrinology (Lausanne) 12 (2021): 683226.

[23] K. Lee, M. Banuls-Mirete, A. F. Lombardi, et al., “Infrapatellar Fat Pad Size and Subcutaneous Fat in Knee Osteoarthritis Radiographic Progression: Data From the Osteoarthritis Initiative,” Arthritis Research & Therapy 1 (2024): 145.

[24] F. Motta, E. Barone, A. Sica, et al., “Inflammaging and Osteoarthritis,” Clinical Reviews in Allergy & Immunology 2 (2023): 222–238.

[25] R. N. Almeheyawi, A. Bricca, J. L. Riskowski, et al., “Foot Characteristics and Mechanics in Individuals With Knee Osteoarthritis: Systematic Review and Meta-analysis,” Journal of Foot and Ankle Research 1 (2021): 24.

[26] M. Gulati, E. Dursun, K. Vincent, et al., “The Influence of Sex Hormones on Musculoskeletal Pain and Osteoarthritis,” The Lancet Rheumatology 4 (2023): e225–e238.

[27] P. Kreitmaier, M. Suderman, L. Southam, et al., “An Epigenome-wide View of Osteoarthritis in Primary Tissues,” American Journal of Human Genetics 7 (2022): 1255–1271.

[28] J. Steinberg, L. Southam, T. I. Roumeliotis, et al., “A Molecular Quantitative Trait Locus Map for Osteoarthritis,” Nature Communications 1 (2021): 1309.

[29] A. Courties, F. Berenbaum, and J. Sellam, “The Phenotypic Approach to Osteoarthritis: A Look at Metabolic Syndrome-Associated Osteoarthritis,” Joint, Bone, Spine 6 (2019): 725–730.

[30] H. Xue, L. Zhang, J. Xu, et al., “Association of the Visceral Fat Metabolic Score With Osteoarthritis Risk: A Cross-sectional Study From NHANES 2009–2018,” BMC Public Health [Electronic Resource] 1 (2024): 2269.

[31] M. R. Schmitz, A. S. Murtha, and J. C. Clohisy, “Developmental Dysplasia of the Hip in Adolescents and Young Adults,” Journal of the American Academy of Orthopaedic Surgeons 3 (2020): 91–101.

[32] M. D. Harris, M. C. Shepherd, K. Song, et al., “The Biomechanical Disadvantage of Dysplastic Hips,” Journal of Orthopaedic Research 6 (2022): 1387–1396.

[33] J. L. Whittaker, J. M. Losciale, C. B. Juhl, et al., “Risk Factors for Knee Osteoarthritis After Traumatic Knee Injury: A Systematic Review and Meta-analysis of Randomised Controlled Trials and Cohort Studies for the OPTIKNEE Consensus,” British Journal of Sports Medicine 24 (2022): 1406–1421.

[34] M. O. Korovina, A. R. Valeeva, I. F. Akhtyamov, et al., “Joint Tissues: Convergence and Divergence of the Pathogenetic Mechanisms of Rheumatoid Arthritis and Osteoarthritis,” International Journal of Molecular Sciences 17 (2025): 8742.

[35] T. Neogi, S. Krasnokutsky, and M. H. Pillinger, “Urate and Osteoarthritis: Evidence for a Reciprocal Relationship,” Joint, Bone, Spine 5 (2019): 576–582.

[36] F. Migliorini, E. Marsilio, E. Torsiello, et al., “Osteoarthritis in Athletes versus Nonathletes: A Systematic Review,” Sports Medicine and Arthroscopy Review 2 (2022): 78–86.

[37] S. Yang, S. Zhang, R. Li, et al., “Chinese Experts Consensus and Practice Guideline on Discoid Lateral Meniscus,” Orthopaedic Surgery 4 (2023): 915–929.

[38] C. Chen, K. T. Tsai, K. T. Yeh, et al., “Association of Scoliosis and Severe Knee Osteoarthritis: A Case-Control Study,” Journal of Clinical Medicine 23 (2024): 7369.

[39] Y. Ma, X. Zhi, and H. Zhang, “Investigation on the Etiology of Patients Undergoing Non-traumatic Total Hip Arthroplasty in China,” Journal of Orthopaedic Surgery (Hong Kong) 1 (2022): 10225536221092114.

[40] T. Sato, S. Yamate, T. Utsunomiya, et al., “Life Course Epidemiology of Hip Osteoarthritis in Japan: A Multicenter, Cross-Sectional Study,” Journal of Bone and Joint Surgery American Volume 11 (2024): 966–975.

[41] J. A. Mitterer, G. M. Schwarz, A. Aichmair, et al., “Multifactorial Pathomechanism of Hip Dysplasia and Femoroacetabular Impingement in Young Adults: The Diamond Concept,” Anthropologischer Anzeiger 2 (2022): 229–243.

[42] T. Nandhagopal, V. Tiwari, and F. L. De Cicco, Developmental Dysplasia of the Hip, in StatPearls (StatPearls Publishing Copyright © 2025, StatPearls Publishing LLC.: Treasure Island (FL), 2025).

[43] D. Hwang, M. W. Choi, S. H. Kim, et al., “Age and Sex Differences in Coronal Lower Extremity Alignment in a Healthy Asian Population,” The Knee 45 (2023): 198–206.

[44] C. Yokose, M. Chen, A. Berhanu, et al., “Gout and Osteoarthritis: Associations, Pathophysiology, and Therapeutic Implications,” Current Rheumatology Reports 10 (2016): 65.

[45] N. Dalbeth, A. L. Gosling, A. Gaffo, et al., “Gout,” Lancet 10287 (2021): 1843–1855.

[46] E. Roddy and M. Doherty, “Gout and Osteoarthritis: A Pathogenetic Link?,” Joint, Bone, Spine 5 (2012): 425–427.

[47] A. Chattopadhyay, J. Samanta, S. K. Sharma, et al., “Classical Hand Radiology of Gout, Osteoarthritis and Diffuse Idiopathic Skeletal Hyperostosis (DISH),” Qjm 5 (2021): 336–337.

[48] Y. Saito, A. Tanaka, K. Node, et al., “Uric Acid and Cardiovascular Disease: A Clinical Review,” Journal of Cardiology 1 (2021): 51–57.

[49] Y. M. Tang, L. Zhang, S. Z. Zhu, et al., “Gout in China, 1990–2017: The Global Burden of Disease Study 2017,” Public Health 191 (2021): 33–38.

[50] GBD 2019 MSK in Adolescents Collaborators. “Global Pattern, Trend, and Cross-country Inequality of Early Musculoskeletal Disorders From 1990 to 2019, With Projection From 2020 to 2050,” Med 8 (2024): 943–962.e946.

[51] C. Yokose, N. McCormick, N. Lu, et al., “Trends in Prevalence of Gout among US Asian Adults, 2011–2018,” JAMA Network Open 4 (2023): e239501.

[52] J. A. Singh and A. Gaffo, “Gout Epidemiology and Comorbidities,” Seminars in Arthritis and Rheumatism 3s (2020): S11–s16.

[53] F. Yang, R. Chen, J. Xiong, et al., “The Disease Burden of Gout in Asian Countries and Regions From 1990 to 2021, Risk Factors and Forecast Analysis: A Systematic Study of Asian Disease Burden in 2021,” PLoS One 7 (2025): e0328543.

[54] L. R. Harrold, C. J. Etzel, A. Gibofsky, et al., “Sex Differences in Gout Characteristics: Tailoring Care for Women and Men,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2017): 108.

[55] J. E. Dilley, M. A. Bello, N. Roman, et al., “Post-traumatic Osteoarthritis: A Review of Pathogenic Mechanisms and Novel Targets for Mitigation,” Bone Reports 18 (2023): 101658.

[56] K. E. Webster and T. E. Hewett, “Anterior Cruciate Ligament Injury and Knee Osteoarthritis: An Umbrella Systematic Review and Meta-analysis,” Clinical Journal of Sport Medicine 2 (2022): 145–152.

[57] P. A. Deleu, T. Leemrijse, L. Chèze, et al., “Post-sprain versus Post-fracture Post-traumatic Ankle Osteoarthritis: Impact on Foot and Ankle Kinematics and Kinetics,” Gait & Posture 86 (2021): 278–286.

[58] P. A. Deleu, A. Naaim, L. Chèze, et al., “The Effect of Ankle and Hindfoot Malalignment on Foot Mechanics in Patients Suffering From Post-traumatic Ankle Osteoarthritis,” Clin Biomech (Bristol) 81 (2021): 105239.

[59] Y. Lai-Zhao, K. K. Pitchers, and C. T. Appleton, “Transient Anabolic Effects of Synovium in Early Post-traumatic Osteoarthritis: A Novel Ex Vivo Joint Tissue co-culture System for Investigating Synovium-chondrocyte Interactions,” Osteoarthritis and Cartilage 7 (2021): 1060–1070.

[60] T. M. Pham, J. L. Erichsen, J. M. Kowal, et al., “Elevation of Pro-Inflammatory Cytokine Levels Following Intra-Articular Fractures-A Systematic Review,” Cells 4 (2021): 902.

[61] V. B. Kraus and M. F. Hsueh, “Molecular Biomarker Approaches to Prevention of Post-traumatic Osteoarthritis,” Nature Reviews Rheumatology 5 (2024): 272–289.

[62] M. Chammas, “Post-traumatic Osteoarthritis of the Elbow,” Orthopaedics and Traumatology: Surgery and Research 1, no. l (2014): S15–24.

[63] J. J. Cush, “Rheumatoid Arthritis: Early Diagnosis and Treatment,” Medical Clinics of North America 2 (2021): 355–365.

[64] J. S. Smolen, D. Aletaha, and I. B. McInnes, “Rheumatoid Arthritis,” Lancet 10055 (2016): 2023–2038.

[65] M. L. Hetland, E. A. Haavardsholm, A. Rudin, et al., “Active Conventional Treatment and Three Different Biological Treatments in Early Rheumatoid Arthritis: Phase IV Investigator Initiated, Randomised, Observer Blinded Clinical Trial,” Bmj 371 (2020): m4328.

[66] A. H. Hoveidaei, A. Nakhostin-Ansari, M. Chalian, et al., “Burden of Knee Osteoarthritis in the Middle East and North Africa (MENA): An Epidemiological Analysis From 1990 to 2019,” Archives of Orthopaedic and Trauma Surgery 10 (2023): 6323–6333.

[67] E. Li, J. Tan, K. Xu, et al., “Global Burden and Socioeconomic Impact of Knee Osteoarthritis: A Comprehensive Analysis,” Frontiers in Medicine (Lausanne) 11 (2024): 1323091.

[68] Y. Kang, C. Liu, Y. Ji, et al., “The Burden of Knee Osteoarthritis Worldwide, Regionally, and Nationally From 1990 to 2019, Along With an Analysis of Cross-national Inequalities,” Archives of Orthopaedic and Trauma Surgery 6 (2024): 2731–2743.

[69] V. Duong, C. Abdel Shaheed, M. L. Ferreira, et al., “Risk Factors for the Development of Knee Osteoarthritis Across the Lifespan: A Systematic Review and Meta-analysis,” Osteoarthritis and Cartilage 10 (2025): 1162–1179.

[70] Y. Dong, Y. Yan, J. Zhou, et al., “Evidence on Risk Factors for Knee Osteoarthritis in Middle-older Aged: A Systematic Review and Meta Analysis,” Journal of Orthopaedic Surgery and Research 1 (2023): 634.

[71] T. Frydendal, R. Christensen, I. Mechlenburg, et al., “Total Hip Replacement or Resistance Training for Severe Hip Osteoarthritis,” New England Journal of Medicine 17 (2024): 1610–1620.

[72] E. C. Harris and D. Coggon, “HIP Osteoarthritis and Work,” Best Practice & Research Clinical Rheumatology 3 (2015): 462–482.

[73] Z. Fan, L. Yan, H. Liu, et al., “The Prevalence of Hip Osteoarthritis: A Systematic Review and Meta-analysis,” Arthritis Research & Therapy 1 (2023): 51.

[74] A. H. Hoveidaei, A. Nakhostin-Ansari, S. H. Hosseini-Asl, et al., “Increasing Burden of Hip Osteoarthritis in the Middle East and North Africa (MENA): An Epidemiological Analysis From 1990 to 2019,” Archives of Orthopaedic and Trauma Surgery 6 (2023): 3563–3573.

[75] H. Jonsson, “Age Related Prevalence of Hand Osteoarthritis Diagnosed by Photography (HOASCORE),” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2017): 508.

[76] J. Xu, Y. Zeng, H. Si, et al., “Integrating Transcriptome-wide Association Study and mRNA Expression Profile Identified Candidate Genes Related to Hand Osteoarthritis,” Arthritis Research & Therapy 1 (2021): 81.

[77] V. Gracia-Ibáñez, M. J. Agost, V. Bayarri-Porcar, et al., “Hand Kinematics in Osteoarthritis Patients While Performing Functional Activities,” Disability and Rehabilitation 7 (2023): 1124–1130.

[78] A. H. Hoveidaei, A. Nakhostin-Ansari, M. Chalian, et al., “Burden of Hand Osteoarthritis in the Middle East and North Africa (MENA): An Epidemiological Analysis from 1990 to 2019,” Journal of Hand Surgery American 3 (2023): 245–256.

[79] L. D. A. Paget, J. L. Tol, G. Kerkhoffs, et al., “Health-Related Quality of Life in Ankle Osteoarthritis: A Case-Control Study,” Cartilage 13, no. 1_suppl (2021): 1438s–1444s.

[80] L. F. Valesan, C. D. Da-Cas, J. C. Réus, et al., “Prevalence of Temporomandibular Joint Disorders: A Systematic Review and Meta-analysis,” Clinical Oral Investigations 2 (2021): 441–453.

[81] Osteoarthritis, E.G.o.C.G.f.D.a.T.o., T.P.D.B.o.t.C.A.W. Association, H. Dong F. Zeguo, H. Rong, et al., “Chinese Guidelines for Diagnosis and Treatment of Osteoarthritis (2024 edition),” Chinese Journal of Pain 3 (2024): 323–338.

[82] C. P. Hannon, S. M. Goodman, M. S. Austin, et al., “2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients with Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis with Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective,” Arthritis & Rheumatology 11 (2023): 1877–1888.

[83] R. Altman, G. Alarcon, D. Appelrouth, et al., “The American College of Rheumatology Criteria for the Classification and Reporting of Osteoarthritis of the Hand,” Arthritis and Rheumatism 11 (1990): 1601–1610.

[84] T. Moseng, T. P. M. Vliet Vlieland, S. Battista, et al., “EULAR Recommendations for the Non-pharmacological Core Management of Hip and Knee Osteoarthritis: 2023 Update,” Annals of the Rheumatic Diseases 6 (2024): 730–740.

[85] I. K. Haugen, D. T. Felson, A. Abhishek, et al., “2023 EULAR Classification Criteria for Hand Osteoarthritis,” Annals of the Rheumatic Diseases 11 (2024): 1428–1435.

[86] N. Holzer, D. Salvo, A. C. Marijnissen, et al., “Radiographic Evaluation of Posttraumatic Osteoarthritis of the Ankle: The Kellgren-Lawrence Scale Is Reliable and Correlates With Clinical Symptoms,” Osteoarthritis and Cartilage 3 (2015): 363–369.

[87] L. E. Rasmussen, A. G. Hoffmann, P. Blanche, et al., “Surgeon Training and Revision Rates after Patellofemoral Arthroplasty,” JAMA Network Open 6 (2025): e2517825.

[88] D. C. Santana, S. R. Oak, Y. Jin, et al., “Increased Joint Space Narrowing after Arthroscopic Partial Meniscectomy: Data from the Osteoarthritis Initiative,” American Journal of Sports Medicine 8 (2022): 2075–2082.

[89] J. Lee, J. M. Kim, B. S. Lee, et al., “Long-Term Results of Meniscus Allograft Transplantation with Bone Fixation Show Improved Outcomes but Progression of Joint Space Narrowing, Osteoarthritis, and Cartilage Degeneration,” Arthroscopy 7 (2025): 2405–2411.

[90] J. Pan, Y. Wu, Z. Tang, et al., “Automatic Knee Osteoarthritis Severity Grading Based on X-ray Images Using a Hierarchical Classification Method,” Arthritis Research & Therapy 1 (2024): 203.

[91] X. Han, J. Cui, L. Chu, et al., “Abnormal Subchondral Trabecular Bone Remodeling in Knee Osteoarthritis Under the Influence of Knee Alignment,” Osteoarthritis and Cartilage 1 (2022): 100–109.

[92] M. A. J. Finnila, S. Das Gupta, M. J. Turunen, et al., “Mineral Crystal Thickness in Calcified Cartilage and Subchondral Bone in Healthy and Osteoarthritic Human Knees,” Journal of Bone and Mineral Research 9 (2022): 1700–1710.

[93] S. B. Kim, Y. J. Kim, J. Y. Jung, et al., “Classification of Grades of Subchondral Sclerosis From Knee Radiographic Images Using Artificial Intelligence,” Sensors (Basel) 8 (2025): 2535.

[94] M. A. Smolle, C. Goetz, D. Maurer, et al., “Artificial Intelligence-based Computer-aided System for Knee Osteoarthritis Assessment Increases Experienced Orthopaedic Surgeons' agreement Rate and Accuracy,” Knee Surgery, Sports Traumatology, Arthroscopy 3 (2023): 1053–1062.

[95] W. M. Oo and M. T. Bo, “Role of Ultrasonography in Knee Osteoarthritis,” Journal of Clinical Rheumatology 6 (2016): 324–329.

[96] M. Backhaus, G. R. Burmester, T. Gerber, et al., “Guidelines for Musculoskeletal Ultrasound in Rheumatology,” Annals of the Rheumatic Diseases 7 (2001): 641–649.

[97] T. McAlindon, E. Kissin, L. Nazarian, et al., “American College of Rheumatology Report on Reasonable Use of Musculoskeletal Ultrasonography in Rheumatology Clinical Practice,” Arthritis Care Res (Hoboken) 11 (2012): 1625–1640.

[98] C. Andersen, J. F. Griffin, S. Jacobsen, et al., “Validation of Ultrasonography for Measurement of Cartilage Thickness in the Equine Carpus,” Veterinary Radiology & Ultrasound: The Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association 4 (2022): 478–489.

[99] E. Naredo, C. Acebes, I. Moller, et al., “Ultrasound Validity in the Measurement of Knee Cartilage Thickness,” Annals of the Rheumatic Diseases 8 (2009): 1322–1327.

[100] C. L. Lee, M. H. Huang, C. Y. Chai, et al., “The Validity of in Vivo Ultrasonographic Grading of Osteoarthritic Femoral Condylar Cartilage: A Comparison With in Vitro Ultrasonographic and Histologic Gradings,” Osteoarthritis and Cartilage 3 (2008): 352–358.

[101] C. Y. Tsai, C. L. Lee, C. Y. Chai, et al., “The Validity of in Vitro Ultrasonographic Grading of Osteoarthritic Femoral Condylar Cartilage–a Comparison With Histologic Grading,” Osteoarthritis and Cartilage 3 (2007): 245–250.

[102] Y. J. Chen, C. H. Chen, C. L. Wang, et al., “Association Between the Severity of Femoral Condylar Cartilage Erosion Related to Knee Osteoarthritis by Ultrasonographic Evaluation and the Clinical Symptoms and Functions,” Archives of Physical Medicine and Rehabilitation 5 (2015): 837–844.

[103] I. Moller, D. Bong, E. Naredo, et al., “Ultrasound in the Study and Monitoring of Osteoarthritis,” Osteoarthritis and Cartilage 16 (2008): S4–S7.

[104] A. M. Abraham, I. Goff, M. S. Pearce, et al., “Reliability and Validity of Ultrasound Imaging of Features of Knee Osteoarthritis in the Community,” BMC Musculoskeletal Disorders [Electronic Resource] 12 (2011): 70.

[105] M. Saito, H. Ito, A. Okahata, et al., “Ultrasonographic Changes of the Knee Joint Reflect Symptoms of Early Knee Osteoarthritis in General Population; the Nagahama Study,” Cartilage 1 (2022): 19476035221077403.

[106] J. M. Koski, A. Kamel, P. Waris, et al., “Atlas-based Knee Osteophyte Assessment With Ultrasonography and Radiography: Relationship to Arthroscopic Degeneration of Articular Cartilage,” Scandinavian Journal of Rheumatology 2 (2016): 158–164.

[107] M. T. Nevalainen, K. V. Kauppinen, T. Niinimaki, et al., “Comparison of Ultrasonographic, Radiographic and Intra-operative Findings in Severe Hip Osteoarthritis,” Scientific Reports 1 (2020): 21108.

[108] T. Okano, E. Filippucci, M. Di Carlo, et al., “Ultrasonographic Evaluation of Joint Damage in Knee Osteoarthritis: Feature-specific Comparisons With Conventional Radiography,” Rheumatology (Oxford) 11 (2016): 2040–2049.

[109] B. F. Riecke, R. Christensen, S. Torp-Pedersen, et al., “An Ultrasound Score for Knee Osteoarthritis: A Cross-sectional Validation Study,” Osteoarthritis and Cartilage 10 (2014): 1675–1691.

[110] J. Zhu, B. Li, L. Qiu, et al., “A Measurement Method of Knee Joint Space Width by Ultrasound: A Large Multicenter Study,” Quantitative Imaging in Medicine and Surgery 5 (2020): 979–987.

[111] J. Ramirez, C. D. Adao-Abe, A. Mocritcaia, et al., “Ultrasound-detected Lumps in Synovial Fluid, a Sonographic Finding Associated With Non-inflammatory Joint Effusion,” Clinical and Experimental Rheumatology 9 (2025): 1577–1581.

[112] N. Maricar, M. J. Callaghan, M. J. Parkes, et al., “Clinical Assessment of Effusion in Knee Osteoarthritis-A Systematic Review,” Seminars in Arthritis and Rheumatism 5 (2016): 556–563.

[113] M. A. D'Agostino, P. Conaghan, M. L. Bars, et al., “EULAR Report on the Use of Ultrasonography in Painful Knee Osteoarthritis. Part 1: Prevalence of Inflammation in Osteoarthritis,” Annals of the Rheumatic Diseases 12 (2005): 1703–1709.

[114] N. A. Elsawy, A. H. Ibrahiem, G. A. Younis, et al., “Clinical Examination, Ultrasound Assessment and Aspiration of Knee Effusion in Primary Knee Osteoarthritis Patients,” Journal of Orthopaedic Surgery and Research 1 (2023): 422.

[115] E. de Miguel Mendieta, T. Cobo Ibanez, J. U. Jaeger, et al., “Clinical and Ultrasonographic Findings Related to Knee Pain in Osteoarthritis,” Osteoarthritis and Cartilage 6 (2006): 540–544.

[116] B. B. Mermerci, Y. Garip, R. S. Uysal, et al., “Clinic and Ultrasound Findings Related to Pain in Patients With Knee Osteoarthritis,” Clinical Rheumatology 8 (2011): 1055–1062.

[117] M. Hall, S. Doherty, P. Courtney, et al., “Synovial Pathology Detected on Ultrasound Correlates With the Severity of Radiographic Knee Osteoarthritis More Than With Symptoms,” Osteoarthritis and Cartilage 10 (2014): 1627–1633.

[118] Y. Mizuno, Y. Takata, Y. Shima, et al., “Relationship Between Ultrasonographic Findings and Subscales of the Knee Injury and Osteoarthritis Outcome Score in Patients With Early Knee Osteoarthritis: A Multicenter Study,” Journal of Medical Ultrasound (2001) 1 (2025): 139–148.

[119] B. Abbasi, M. Pezeshki-Rad, R. Akhavan, et al., “Association Between Clinical and Sonographic Synovitis in Patients With Painful Knee Osteoarthritis,” International Journal of Rheumatic Diseases 5 (2017): 561–566.

[120] Y. Pan, L. Wang, and L. Zhou, “The Investigation of the Application Value of Musculoskeletal Ultrasound in the Diagnosis and Conservative Treatment of Knee Osteoarthritis,” Disease Markers 2022 (2022): 9660067.

[121] P. Molyneux, C. Bowen, R. Ellis, et al., “Development of an Ultrasound Imaging Atlas for Grading Osteoarthritis in the First Metatarsophalangeal Joint,” Arthritis Care & Research (Hoboken) 11 (2024): 1501–1510.

[122] F. W. Roemer, A. Guermazi, S. Demehri, et al., “Imaging in Osteoarthritis,” Osteoarthritis and Cartilage 7 (2022): 913–934.

[123] A. S. Chaudhari, F. Kogan, V. Pedoia, et al., “Rapid Knee MRI Acquisition and Analysis Techniques for Imaging Osteoarthritis,” Journal of Magnetic Resonance Imaging 5 (2020): 1321–1339.

[124] D. Herrera, A. Almhdie-Imjabbar, H. Toumi, et al., “Magnetic Resonance Imaging-based Biomarkers for Knee Osteoarthritis Outcomes: A Narrative Review of Prediction but Not Association Studies,” European Journal of Radiology 181 (2024): 111731.

[125] A. Morales Martinez, F. Caliva, I. Flament, et al., “Learning Osteoarthritis Imaging Biomarkers From Bone Surface Spherical Encoding,” Magnetic Resonance in Medicine 4 (2020): 2190–2203.

[126] A. Tack, F. Ambellan, and S. Zachow, “Towards Novel Osteoarthritis Biomarkers: Multi-criteria Evaluation of 46,996 Segmented Knee MRI Data From the Osteoarthritis Initiative,” PLoS One 10 (2021): e0258855.

[127] A. Razmjoo, F. Caliva, J. Lee, et al., “T(2) Analysis of the Entire Osteoarthritis Initiative Dataset,” Journal of Orthopaedic Research 1 (2021): 74–85.

[128] K. Yu, J. Ying, T. Zhao, et al., “Prediction Model for Knee Osteoarthritis Using Magnetic Resonance-based Radiomic Features From the Infrapatellar Fat Pad: Data From the Osteoarthritis Initiative,” Quantitative Imaging in Medicine and Surgery 1 (2023): 352–369.

[129] J. E. Collins, E. Losina, M. C. Nevitt, et al., “Semiquantitative Imaging Biomarkers of Knee Osteoarthritis Progression: Data from the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium,” Arthritis Rheumatology 10 (2016): 2422–2431.

[130] Y. Sun, C. Deng, Z. Zhang, et al., “Novel Nomogram for Predicting the Progression of Osteoarthritis Based on 3D-MRI Bone Shape: Data From the FNIH OA Biomarkers Consortium,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2021): 782.

[131] D. Hunter, M. Nevitt, J. Lynch, et al., “Longitudinal Validation of Periarticular Bone Area and 3D Shape as Biomarkers for Knee OA Progression? Data From the FNIH OA Biomarkers Consortium,” Annals of the Rheumatic Diseases 9 (2016): 1607–1614.

[132] S. Sakurai, T. Nakasa, Y. Ikuta, et al., “The Relationship between Calcaneofibular Ligament Injury and Ankle Osteoarthritis Progression: A Comprehensive Analysis of Stress Distribution and Osteophyte Formation in the Subtalar Joint,” Foot & Ankle International 8 (2024): 870–878.

[133] C. Deng, Y. Sun, Z. Zhang, et al., “Development and Evaluation of Nomograms for Predicting Osteoarthritis Progression Based on MRI Cartilage Parameters: Data From the FNIH OA biomarkers Consortium,” BMC Medical Imaging 1 (2023): 43.

[134] N. Hafezi-Nejad, A. Guermazi, F. W. Roemer, et al., “Prediction of Medial Tibiofemoral Compartment Joint Space Loss Progression Using Volumetric Cartilage Measurements: Data From the FNIH OA Biomarkers Consortium,” European Radiology 2 (2017): 464–473.

[135] J. W. MacKay, G. Kapoor, J. B. Driban, et al., “Association of Subchondral Bone Texture on Magnetic Resonance Imaging With Radiographic Knee Osteoarthritis Progression: Data From the Osteoarthritis Initiative Bone Ancillary Study,” European Radiology 11 (2018): 4687–4695.

[136] H. Zhong, D. J. Miller, and K. L. Urish, “T2 map Signal Variation Predicts Symptomatic Osteoarthritis Progression: Data From the Osteoarthritis Initiative,” Skeletal Radiology 7 (2016): 909–913.

[137] M. Attur, S. Krasnokutsky, H. Zhou, et al., “The Combination of an Inflammatory Peripheral Blood Gene Expression and Imaging Biomarkers Enhance Prediction of Radiographic Progression in Knee Osteoarthritis,” Arthritis Research & Therapy 1 (2020): 208.

[138] G. B. Joseph, C. E. McCulloch, M. C. Nevitt, et al., “Tool for Osteoarthritis Risk Prediction (TOARP) Over 8 Years Using Baseline Clinical Data, X-ray, and MRI: Data From the Osteoarthritis Initiative,” Journal of Magnetic Resonance Imaging 6 (2018): 1517–1526.

[139] T. Lin, S. Peng, S. Lu, et al., “Prediction of Knee Pain Improvement Over Two Years for Knee Osteoarthritis Using a Dynamic Nomogram Based on MRI-derived Radiomics: A Proof-of-concept Study,” Osteoarthritis and Cartilage 2 (2023): 267–278.

[140] D. J. Hunter, L. A. Deveza, J. E. Collins, et al., “Multivariable Modeling of Biomarker Data from the Phase I Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium,” Arthritis Care Res (Hoboken) 7 (2022): 1142–1153.

[141] R. Wu, Y. Ma, Y. Yang, et al., “A Clinical Model for Predicting Knee Replacement in Early-stage Knee Osteoarthritis: Data From Osteoarthritis Initiative,” Clinical Rheumatology 4 (2022): 1199–1210.

[142] C. K. Kwoh, H. Guehring, A. Aydemir, et al., “Predicting Knee Replacement in Participants Eligible for Disease-modifying Osteoarthritis Drug Treatment With Structural Endpoints,” Osteoarthritis and Cartilage 6 (2020): 782–791.

[143] A. A. Tolpadi, J. J. Lee, V. Pedoia, et al., “Deep Learning Predicts Total Knee Replacement From Magnetic Resonance Images,” Scientific Reports 1 (2020): 6371.

[144] H. R. Rajamohan, T. Wang, K. Leung, et al., “Prediction of Total Knee Replacement Using Deep Learning Analysis of Knee MRI,” Scientific Reports 1 (2023): 6922.

[145] T. D. Turmezei, B. S. Low, S. Rupret, et al., “Quantitative Three-dimensional Assessment of Knee Joint Space Width From Weight-bearing CT,” Radiology 3 (2021): 649–659.

[146] B. Fritz, J. Fritz, S. F. Fucentese, et al., “Three-dimensional Analysis for Quantification of Knee Joint Space Width With Weight-bearing CT: Comparison With Non-weight-bearing CT and Weight-bearing Radiography,” Osteoarthritis and Cartilage 5 (2022): 671–680.

[147] G. Vincent, R. Marchand, M. A. Mont, et al., “Characterizing Osteophyte Formation in Knee Osteoarthritis: Application of Machine Learning Quantification of a Computerized Tomography Cohort: Implications for Treatment,” Journal of Arthroplasty 11 (2024): 2692–2701.

[148] H. Zhao, H. Li, X. Xie, et al., “Dual-energy CT Virtual Non-calcium: An Accurate Method for Detection of Knee Osteoarthritis-related Edema-Like Marrow Signal Intensity,” Insights Imaging 1 (2023): 74.

[149] W. Chen, L. Liu, H. Zhao, et al., “Dual-energy CT-derived Virtual Noncalcium Imaging to Assess Bone Marrow Lesions in Patients With Knee Osteoarthritis,” Scientific Reports 1 (2025): 3331.

[150] R. A. Beynon, F. R. Saunders, R. Ebsim, et al., “Dual-energy X-ray Absorptiometry Derived Knee Shape May Provide a Useful Imaging Biomarker for Predicting Total Knee Replacement: Findings From a Study of 37,843 People in UK Biobank,” Osteoarthr Cartil Open 2 (2024): 100468.

[151] R. A. Beynon, F. Alomar, F. R. Saunders, et al., “Use of Dual-energy X-ray Absorptiometry to Evaluate Variation in Bone Shape and Alignment Associated With Radiographic Knee Osteoarthritis: Findings From a Study of 19,053 Individuals in UK Biobank,” Osteoarthr Cartil Open 4 (2025): 100667.

[152] M. D. Kohn, A. A. Sassoon, and N. D. Fernando, “Classifications in Brief: Kellgren-Lawrence Classification of Osteoarthritis,” Clinical Orthopaedics and Related Research 8 (2016): 1886–1893.

[153] A. J. Burge and S. T. Jawetz, “Advanced Magnetic Resonance Imaging in Osteoarthritis,” Seminars in Musculoskeletal Radiology 4 (2020): 355–366.

[154] F. Caliva, N. K. Namiri, M. Dubreuil, et al., “Studying Osteoarthritis With Artificial Intelligence Applied to Magnetic Resonance Imaging,” Nature Reviews Rheumatology 2 (2022): 112–121.

[155] A. K. Carlson, R. A. Rawle, E. Adams, et al., “Application of Global Metabolomic Profiling of Synovial Fluid for Osteoarthritis Biomarkers,” Biochemical and Biophysical Research Communications 2 (2018): 182–188.

[156] M. Jiang, T. Chen, H. Feng, et al., “Serum Metabolic Signatures of Four Types of human Arthritis,” Journal of Proteome Research 8 (2013): 3769–3779.

[157] A. Mobasheri, C. S. Thudium, A. C. Bay-Jensen, et al., “Biomarkers for Osteoarthritis: Current Status and Future Prospects,” Best Practice & Research Clinical Rheumatology 2 (2023): 101852.

[158] W. Liu, N. Y. Guo, J. Q. Wang, and B. B. Xu, “Osteoarthritis: Mechanisms and Therapeutic Advances,” MedComm 8 (2025): e70290.

[159] V. Molnar, V. Matisic, I. Kodvanj, et al., “Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis,” International Journal of Molecular Sciences 17 (2021): 9208.

[160] T. Mabey, S. Honsawek, A. Tanavalee, et al., “Plasma and Synovial Fluid Inflammatory Cytokine Profiles in Primary Knee Osteoarthritis,” Biomarkers 7 (2016): 639–644.

[161] T. Silvestri, L. Pulsatelli, P. Dolzani, et al., “Elevated Serum Levels of Soluble Interleukin-4 Receptor in Osteoarthritis,” Osteoarthritis and Cartilage 7 (2006): 717–719.

[162] Y. Shan, C. Qi, Y. Liu, et al., “Increased Frequency of Peripheral Blood Follicular Helper T Cells and Elevated Serum IL-21 Levels in Patients With Knee Osteoarthritis,” Molecular Medicine Reports 3 (2017): 1095–1102.

[163] M. Laavola, T. Leppanen, M. Hamalainen, et al., “IL-6 in Osteoarthritis: Effects of Pine Stilbenoids,” Molecules 1 (2018): 109.

[164] A. Mihailova, “Interleukin 6 Concentration in Synovial Fluid of Patients With Inflammatory and Degenerative Arthritis,” Curr Rheumatol Rev 3 (2022): 230–233.

[165] F. Doss, J. Menard, M. Hauschild, et al., “Elevated IL-6 Levels in the Synovial Fluid of Osteoarthritis Patients Stem From Plasma Cells,” Scandinavian Journal of Rheumatology 2 (2007): 136–139.

[166] J. M. Schulz, T. B. Birmingham, H. T. Philpott, et al., “Changes and Associations Between Synovial Fluid and Magnetic Resonance Imaging Markers of Osteoarthritis After High Tibial Osteotomy,” Arthritis Research & Therapy 1 (2024): 176.

[167] T. E. McAlindon, J. L. Hunnicutt, M. B. Roberts, et al., “Associations of Inflammatory and Metabolic Biomarkers With Incident Erosive Hand Osteoarthritis in the Osteoarthritis Initiative Cohort,” Osteoarthritis and Cartilage 5 (2024): 592–600.

[168] B. Chen, Y. Deng, Y. Tan, et al., “Association Between Severity of Knee Osteoarthritis and Serum and Synovial Fluid Interleukin 17 Concentrations,” Journal of International Medical Research 1 (2014): 138–144.

[169] H. Peters, J. S. Rockel, C. B. Little, et al., “Synovial Fluid as a Complex Molecular Pool Contributing to Knee Osteoarthritis,” Nature Reviews Rheumatology 8 (2025): 447–464.

[170] Y. Liu, H. Peng, Z. Meng, et al., “Correlation of IL-17 Level in Synovia and Severity of Knee Osteoarthritis,” Medical Science Monitor 21 (2015): 1732–1736.

[171] S. J. Snelling, S. Bas, G. J. Puskas, et al., “Presence of IL-17 in Synovial Fluid Identifies a Potential Inflammatory Osteoarthritic Phenotype,” PLoS One 4 (2017): e0175109.

[172] M. Waszczykowski, A. Fabis-Strobin, I. Bednarski, et al., “Serum and Synovial Fluid Concentrations of Interleukin-18 and Interleukin-20 in Patients With Osteoarthritis of the Knee and Their Correlation With Other Markers of Inflammation and Turnover of Joint Cartilage,” Archives of Medical Science 2 (2022): 448–458.

[173] S. Larsson, M. Englund, A. Struglics, et al., “Interleukin-6 and Tumor Necrosis Factor Alpha in Synovial Fluid Are Associated With Progression of Radiographic Knee Osteoarthritis in Subjects With Previous Meniscectomy,” Osteoarthritis and Cartilage 11 (2015): 1906–1914.

[174] S. Min, C. Wang, W. Lu, et al., “Serum Levels of the Bone Turnover Markers Dickkopf-1, Osteoprotegerin, and TNF-alpha in Knee Osteoarthritis Patients,” Clinical Rheumatology 10 (2017): 2351–2358.

[175] Y. C. Su, Y. P. Shen, C. Y. Chang, et al., “The Effect of Intravascular Laser Irradiation of Blood on Serum Biomarkers and Clinical Outcome in Knee Osteoarthritis Patients: A Double-Blind Randomized Control Trial,” International Journal of Molecular Sciences 24 (2024): 13608.

[176] Y. Huang, W. Pan, H. Bao, et al., “Serum and Synovial Fluid Levels of CSF-1 and in Knee Osteoarthritis and Its Clinical Significance,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2025): 353.

[177] P. Wang, “Diagnostic Value of Combined Serum IL-6, TNF-alpha, and Leptin Levels in Patients With Post-Traumatic Osteoarthritis,” Clinica Y Laboratorio 66, no. 10 (2020): 2071.

[178] L. A. Cerezo, A. Navratilova, M. Kuklova, et al., “IL-40 Is Up-regulated in the Synovial Fluid and Cartilage of Osteoarthritis Patients and Contributes to the Alteration of Chondrocytes Phenotype in Vitro,” Arthritis Research & Therapy 1 (2024): 146.

[179] P. Castrogiovanni, M. Di Rosa, S. Ravalli, et al., “Moderate Physical Activity as a Prevention Method for Knee Osteoarthritis and the Role of Synoviocytes as Biological Key,” International Journal of Molecular Sciences 3 (2019): 511.

[180] J. Ding, X. Niu, Y. Su, et al., “Expression of Synovial Fluid Biomarkers in Patients With Knee Osteoarthritis and Meniscus Injury,” Exp Ther Med 2 (2017): 1609–1613.

[181] A. Economou, I. Mallia, A. Fioravanti, et al., “The Role of Adipokines Between Genders in the Pathogenesis of Osteoarthritis,” International Journal of Molecular Sciences 19 (2024): 10865.

[182] C. Xie and Q. Chen, “Adipokines: New Therapeutic Target for Osteoarthritis?,” Current Rheumatology Reports 12 (2019): 71.

[183] S. Min, T. Shi, X. Han, et al., “Serum Levels of Leptin, Osteopontin, and Sclerostin in Patients With and Without Knee Osteoarthritis,” Clinical Rheumatology 1 (2021): 287–294.

[184] A. Cordero-Barreal, M. Gonzalez-Rodriguez, C. Ruiz-Fernandez, et al., “An Update on the Role of Leptin in the Immuno-Metabolism of Cartilage,” International Journal of Molecular Sciences 5 (2021): 2411.

[185] A. Koskinen, K. Vuolteenaho, R. Nieminen, et al., “Leptin Enhances MMP-1, MMP-3 and MMP-13 Production in human Osteoarthritic Cartilage and Correlates With MMP-1 and MMP-3 in Synovial Fluid From OA Patients,” Clinical and Experimental Rheumatology 1 (2011): 57–64.

[186] I. Gianopoulos, C. S. Mantzoros, and S. S. Daskalopoulou, “Adiponectin and Adiponectin Receptors in Atherosclerosis,” Endocrine Reviews 1 (2025): 1–25.

[187] K. Ohashi, J. L. Parker, N. Ouchi, et al., “Adiponectin Promotes Macrophage Polarization Toward an Anti-inflammatory Phenotype,” Journal of Biological Chemistry 9 (2010): 6153–6160.

[188] X. Feng, J. Xiao, and L. Bai, “Role of Adiponectin in Osteoarthritis,” Frontiers in Cell and Developmental Biology 10 (2022): 992764.

[189] I. Ilia, D. Nitusca, and C. Marian, “Adiponectin in Osteoarthritis: Pathophysiology, Relationship With Obesity and Presumptive Diagnostic Biomarker Potential,” Diagnostics (Basel) 2 (2022): 455.

[190] D. Hao, M. Li, Z. Wu, et al., “Synovial Fluid Level of Adiponectin Correlated With Levels of Aggrecan Degradation Markers in Osteoarthritis,” Rheumatology International 11 (2011): 1433–1437.

[191] C. Orellana, J. Calvet, A. Berenguer-Llergo, et al., “Synovial Adiponectin Was More Associated With Clinical Severity Than Synovial Leptin in Women With Knee Osteoarthritis,” Cartilage 1_suppl (2021): 1675S–1683S.

[192] C. W. Zhao, W. X. Song, B. Liu, et al., “Resistin Induces Chemokine and Matrix Metalloproteinase Production via CAP1 Receptor and Activation of p38-MAPK and NF-kappaB Signalling Pathways in human Chondrocytes,” Clinical and Experimental Rheumatology 3 (2022): 501–513.

[193] Z. Li, X. Wang, H. Pan, et al., “Resistin Promotes CCL4 Expression Through Toll-Like Receptor-4 and Activation of the p38-MAPK and NF-kappaB Signaling Pathways: Implications for Intervertebral Disc Degeneration,” Osteoarthritis and Cartilage 2 (2017): 341–350.

[194] A. Koskinen, K. Vuolteenaho, T. Moilanen, et al., “Resistin as a Factor in Osteoarthritis: Synovial Fluid Resistin Concentrations Correlate Positively With Interleukin 6 and Matrix Metalloproteinases MMP-1 and MMP-3,” Scandinavian Journal of Rheumatology 3 (2014): 249–253.

[195] Y. Z. Song, J. Guan, H. J. Wang, et al., “Possible Involvement of Serum and Synovial Fluid Resistin in Knee Osteoarthritis: Cartilage Damage, Clinical, and Radiological Links,” Journal of Clinical Laboratory Analysis 5 (2016): 437–443.

[196] J. Calvet, C. Orellana, N. Albinana Gimenez, et al., “Differential Involvement of Synovial Adipokines in Pain and Physical Function in Female Patients With Knee Osteoarthritis. A Cross-sectional Study,” Osteoarthritis and Cartilage 2 (2018): 276–284.

[197] G. K. Vasileiadis, A. C. Lundell, Y. Zhang, et al., “Adipocytokines in Untreated Newly Diagnosed Rheumatoid Arthritis: Association With Circulating Chemokines and Markers of Inflammation,” Biomolecules 2 (2021): 325.

[198] H. Sato, S. Muraoka, N. Kusunoki, et al., “Resistin Upregulates Chemokine Production by Fibroblast-Like Synoviocytes From Patients With Rheumatoid Arthritis,” Arthritis Research & Therapy 1 (2017): 263.

[199] T. F. Fischer and A. G. Beck-Sickinger, “Chemerin—exploring a Versatile Adipokine,” Biological Chemistry 7 (2022): 625–642.

[200] E. Vasileva, T. Stankova, K. Batalov, et al., “Association of Serum and Synovial Adipokines (chemerin and resistin) With Inflammatory Markers and Ultrasonographic Evaluation Scores in Patients With Knee Joint Osteoarthritis- a Pilot Study,” Rheumatology International 10 (2024): 1997–2005.

[201] J. Ma, D. S. Niu, N. J. Wan, et al., “Elevated Chemerin Levels in Synovial Fluid and Synovial Membrane From Patients With Knee Osteoarthritis,” Int J Clin Exp Pathol 10 (2015): 13393–13398.

[202] K. Huang, G. Du, L. Li, et al., “Association of Chemerin Levels in Synovial Fluid With the Severity of Knee Osteoarthritis,” Biomarkers 1 (2012): 16–20.

[203] G. Simsek Kaya, G. Yapici Yavuz, and A. Kiziltunc, “Expression of Chemerin in the Synovial Fluid of Patients With Temporomandibular Joint Disorders,” Journal of Oral Rehabilitation 4 (2018): 289–294.

[204] E. Valcamonica, C. B. Chighizola, D. Comi, et al., “Levels of Chemerin and Interleukin 8 in the Synovial Fluid of Patients With Inflammatory Arthritides and Osteoarthritis,” Clinical and Experimental Rheumatology 2 (2014): 243–250.

[205] K. Eisinger, S. Bauer, A. Schaffler, et al., “Chemerin Induces CCL2 and TLR4 in Synovial Fibroblasts of Patients With Rheumatoid Arthritis and Osteoarthritis,” Experimental and Molecular Pathology 1 (2012): 90–96.

[206] E. Franco-Trepat, M. Guillan-Fresco, A. Alonso-Perez, et al., “Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis,” Journal of Clinical Medicine 8 (2019): 1178.

[207] E. Franco-Trepat, A. Alonso-Perez, M. Guillan-Fresco, et al., “Visfatin as a Therapeutic Target for Rheumatoid Arthritis,” Expert Opinion on Therapeutic Targets 7 (2019): 607–618.

[208] S. Junker, K. W. Frommer, G. Krumbholz, et al., “Expression of Adipokines in Osteoarthritis Osteophytes and Their Effect on Osteoblasts,” Matrix Biology 62 (2017): 75–91.

[209] A. Fioravanti, S. Cheleschi, A. De Palma, et al., “Can Adipokines Serum Levels be Used as Biomarkers of Hand Osteoarthritis?,” Biomarkers 3 (2018): 265–270.

[210] W. P. Chen, J. P. Bao, J. Feng, et al., “Increased Serum Concentrations of Visfatin and Its Production by Different Joint Tissues in Patients With Osteoarthritis,” Clinical Chemistry and Laboratory Medicine 8 (2010): 1141–1145.

[211] J. P. Bao, L. F. Jiang, W. P. Chen, et al., “Expression of Vaspin in the Joint and the Levels in the Serum and Synovial Fluid of Patients With Osteoarthritis,” International journal of clinical and experimental medicine 10 (2014): 3447–3453.

[212] J. P. Bao, L. F. Jiang, J. Li, et al., “Visceral Adipose Tissue-derived Serine Protease Inhibitor Inhibits Interleukin-1beta-induced Catabolic and Inflammatory Responses in Murine Chondrocytes,” Molecular Medicine Reports 4 (2014): 2191–2197.

[213] J. Wang, K. Zhang, S. Zhang, et al., “Vaspin Promotes Chondrogenic Differentiation of BMSCs via Akt Activation in Osteoarthritis,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2022): 344.

[214] H. He, M. Lu, H. Shi, et al., “Vaspin Regulated Cartilage Cholesterol Metabolism Through miR155/LXRalpha and Participated in the Occurrence of Osteoarthritis in Rats,” Life Sciences 269 (2021): 119096.

[215] J. Jeon, C. Cho, S. Kim, et al., “Blockade of the Vaspin-AP-1 Axis Inhibits Arthritis Development,” Experimental & Molecular Medicine 3 (2025): 628–636.

[216] X. Li, H. Yu, R. Tian, et al., “FABP4 as a Mediator of Lipid Metabolism and Pregnant Uterine Dysfunction in Obesity,” Advanced science (Weinheim, Baden-Wurttemberg, Germany) 25 (2025): e2501077.

[217] E. M. van der Ark-Vonk, M. V. Puijk, G. Pasterkamp, et al., “The Effects of FABP4 on Cardiovascular Disease in the Aging Population,” Current Atherosclerosis Reports 5 (2024): 163–175.

[218] C. Zhang, T. Li, K. Y. Chiu, et al., “FABP4 as a Biomarker for Knee Osteoarthritis,” Biomarkers in medicine 2 (2018): 107–118.

[219] S. Daniel and J. D. Hulleman, “Exploring Ocular Fibulin-3 (EFEMP1): Anatomical, Age-related, and Species Perspectives,” Biochim Biophys Acta Mol Basis Dis 6 (2024): 167239.

[220] M. S. Nandhu, A. Kwiatkowska, V. Bhaskaran, et al., “Tumor-derived Fibulin-3 Activates Pro-invasive NF-kappaB Signaling in Glioblastoma Cells and Their Microenvironment,” Oncogene 34 (2017): 4875–4886.

[221] X. Xu, C. Yang, X. Yu, et al., “Fibulin-3 Regulates the Inhibitory Effect of TNF-alpha on Chondrocyte Differentiation Partially via the TGF-beta/Smad3 Signaling Pathway,” Biochimica et Biophysica Acta - Molecular Cell Research 9 (2022): 119285.

[222] C. Sanchez, G. Mazzucchelli, C. Lambert, et al., “Comparison of Secretome From Osteoblasts Derived From Sclerotic versus Non-sclerotic Subchondral Bone in OA: A Pilot Study,” PLoS One 3 (2018): e0194591.

[223] A. Hasegawa, T. Yonezawa, N. Taniguchi, et al., “Role of Fibulin 3 in Aging-Related Joint Changes and Osteoarthritis Pathogenesis in Human and Mouse Knee Cartilage,” Arthritis & Rheumatology 3 (2017): 576–585.

[224] J. Runhaar, C. Sanchez, S. Taralla, et al., “Fibulin-3 Fragments Are Prognostic Biomarkers of Osteoarthritis Incidence in Overweight and Obese Women,” Osteoarthritis and Cartilage 4 (2016): 672–678.

[225] H. M. de Visser, C. Sanchez, S. C. Mastbergen, et al., “Fib3-3 as a Biomarker for Osteoarthritis in a Rat Model With Metabolic Dysregulation,” Cartilage 3 (2019): 329–334.

[226] Q. Wu, X. Sun, and L. Du, “Association of Fibulin-3 Concentrations With the Presence and Severity of Knee Osteoarthritis: A Cross-sectional Study,” The Knee 6 (2017): 1369–1373.

[227] M. Atef Nassif, “Fibulin-3 Serum and Urine Levels in the Diagnosis and Severity Assessment of Primary Knee Osteoarthritis,” Reumatologia 5 (2019): 271–276.

[228] A. R. Watkins and H. L. Reesink, “Lubricin in Experimental and Naturally Occurring Osteoarthritis: A Systematic Review,” Osteoarthritis and Cartilage 10 (2020): 1303–1315.

[229] C. Thorson, K. Galicia, A. Burleson, et al., “Matrix Metalloproteinases and Their Inhibitors and Proteoglycan 4 in Patients Undergoing Total Joint Arthroplasty,” Clinical and Applied Thrombosis/Hemostasis 25 (2019): 1076029619828113.

[230] S. Ravalli, M. A. Szychlinska, G. Lauretta, et al., “Investigating Lubricin and Known Cartilage-based Biomarkers of Osteoarthritis,” Expert Review of Molecular Diagnostics 4 (2020): 443–452.

[231] Y. Lee, J. Choi, and N. S. Hwang, “Regulation of Lubricin for Functional Cartilage Tissue Regeneration: A Review,” Biomaterials Research 22 (2018): 9.

[232] G. Musumeci, F. M. Trovato, C. Loreto, et al., “Lubricin Expression in human Osteoarthritic Knee Meniscus and Synovial Fluid: A Morphological, Immunohistochemical and Biochemical Study,” Acta Histochemica 5 (2014): 965–972.

[233] M. A. Szychlinska, P. Castrogiovanni, F. M. Trovato, et al., “Physical Activity and Mediterranean Diet Based on Olive Tree Phenolic Compounds From Two Different Geographical Areas Have Protective Effects on Early Osteoarthritis, Muscle Atrophy and Hepatic Steatosis,” European Journal of Nutrition 2 (2019): 565–581.

[234] H. Ogawa, K. Matsumoto, N. Terabayashi, et al., “Association of Lubricin Concentration in Synovial Fluid and Clinical Status of Osteoarthritic Knee,” Mod Rheumatol 3 (2017): 489–492.

[235] S. A. Flowers, K. A. Thomsson, L. Ali, et al., “Decrease of Core 2 O-glycans on Synovial Lubricin in Osteoarthritis Reduces Galectin-3 Mediated Crosslinking,” Journal of Biological Chemistry 47 (2020): 16023–16036.

[236] A. R. Afshari, V. Chang, K. A. Thomsson, et al., “Glycoproteoforms of Osteoarthritis-associated Lubricin in Plasma and Synovial Fluid,” Molecular & Cellular Proteomics 3 (2025): 100923.

[237] S. Chawla, A. Mainardi, N. Majumder, et al., “Chondrocyte Hypertrophy in Osteoarthritis: Mechanistic Studies and Models for the Identification of New Therapeutic Strategies,” Cells 24 (2022): 4034.

[238] T. Han, T. Zhu, Y. Lu, et al., “Collagen Type X Expression and Chondrocyte Hypertrophic Differentiation During OA and OS Development,” American Journal of Cancer Research 4 (2024): 1784–1801.

[239] Y. He, A. S. Siebuhr, N. U. Brandt-Hansen, et al., “Type X Collagen Levels Are Elevated in Serum From human Osteoarthritis Patients and Associated With Biomarkers of Cartilage Degradation and Inflammation,” BMC Musculoskeletal Disorders [Electronic Resource] 15 (2014): 309.

[240] J. Ren, J. Ma, X. Zhang, et al., “Diagnostic Value of Combined Serum Marker Changes and Quantitative MRI Evaluation of Cartilage Volume of Tibial Plateau in a Surgically-induced Osteoarthritis Dog Model,” Journal of International Medical Research 6 (2017): 2023–2035.

[241] Y. He, T. Manon-Jensen, L. Arendt-Nielsen, et al., “Potential Diagnostic Value of a Type X Collagen Neo-epitope Biomarker for Knee Osteoarthritis,” Osteoarthritis and Cartilage 4 (2019): 611–620.

[242] A. C. Bay-Jensen, A. Mobasheri, C. S. Thudium, et al., “Blood and Urine Biomarkers in Osteoarthritis—an Update on Cartilage Associated Type II Collagen and Aggrecan Markers,” Current Opinion in Rheumatology 1 (2022): 54–60.

[243] I. Gonzalez-Guede, D. Garriguez-Perez, and B. Fernandez-Gutierrez, “Osteochondral Tissue-On-a-Chip: A Novel Model for Osteoarthritis Research,” International Journal of Molecular Sciences 18 (2024): 9834.

[244] Y. Luo, Y. He, D. Reker, et al., “A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage Formation,” International Journal of Molecular Sciences 11 (2018): 4034.

[245] J. C. Rousseau, Y. Zhu, P. Miossec, et al., “Serum Levels of Type IIA Procollagen Amino Terminal Propeptide (PIIANP) Are Decreased in Patients With Knee Osteoarthritis and Rheumatoid Arthritis,” Osteoarthritis and Cartilage 6 (2004): 440–447.

[246] O. V. Nemirovskiy, D. R. Dufield, T. Sunyer, et al., “Discovery and Development of a Type II Collagen Neoepitope (TIINE) Biomarker for Matrix Metalloproteinase Activity: From in Vitro to in Vivo,” Analytical Biochemistry 1 (2007): 93–101.

[247] P. Garnero, T. Conrozier, S. Christgau, et al., “Urinary Type II Collagen C-telopeptide Levels Are Increased in Patients With Rapidly Destructive Hip Osteoarthritis,” Annals of the Rheumatic Diseases 10 (2003): 939–943.

[248] H. Cheng, B. Hao, J. Sun, et al., “C-Terminal Cross-Linked Telopeptides of Type II Collagen as Biomarker for Radiological Knee Osteoarthritis: A Meta-Analysis,” Cartilage 4 (2020): 512–520.

[249] J. G. Convill, G. F. Tawy, A. J. Freemont, et al., “Clinically Relevant Molecular Biomarkers for Use in Human Knee Osteoarthritis: A Systematic Review,” Cartilage 1_suppl (2021): 1511S–1531S.

[250] J. Cui and J. Zhang, “Cartilage Oligomeric Matrix Protein, Diseases, and Therapeutic Opportunities,” International Journal of Molecular Sciences 16 (2022): 9253.

[251] K. Maly, E. Andres Sastre, E. Farrell, et al., “COMP and TSP-4: Functional Roles in Articular Cartilage and Relevance in Osteoarthritis,” International Journal of Molecular Sciences 5 (2021): 2242.

[252] A. O. El Defrawy, T. A. Gheita, H. M. Raslan, et al., “Serum and Synovial Cartilage Oligomeric Matrix Protein Levels in Early and Established Rheumatoid Arthritis,” Zeitschrift Fur Rheumatologie 9 (2016): 917–923.

[253] S. Tseng, A. H. Reddi, and P. E. Di Cesare, “Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis,” Biomark Insights 4 (2009): 33–44.

[254] W. Udomsinprasert, N. Mookkhan, T. Tabtimnark, et al., “Cartilage Oligomeric Matrix Protein as a Potential Biomarker for Knee Osteoarthritis,” Bone Joint Res 6 (2024): 261–271.

[255] A. Akinmade, L. M. Oginni, O. O. Adegbehingbe, et al., “Serum Cartilage Oligomeric Matrix Protein as a Biomarker for Predicting Development and Progression of Knee Osteoarthritis,” International Orthopaedics 3 (2021): 551–557.

[256] Y. Nishida, Y. Hashimoto, K. Orita, et al., “Serum Cartilage Oligomeric Matrix Protein Detects Early Osteoarthritis in Patients with Anterior Cruciate Ligament Deficiency,” Arthroscopy 3 (2022): 873–878.

[257] X. Bi, “Correlation of Serum Cartilage Oligomeric Matrix Protein With Knee Osteoarthritis Diagnosis: A Meta-analysis,” Journal of Orthopaedic Surgery and Research 1 (2018): 262.

[258] J. Plsikova Matejova, T. Spakova, D. Harvanova, et al., “A Preliminary Study of Combined Detection of COMP, TIMP-1, and MMP-3 in Synovial Fluid: Potential Indicators of Osteoarthritis Progression,” Cartilage 2_suppl (2021): 1421S–1430S.

[259] M. Ostojic, J. P. Oliveira, D. Kordic, et al., “Blood and Urine Biomarkers for the Diagnosis of Early Stages of Knee Osteoarthritis: A Systematic Review,” J Exp Orthop 3 (2024): e12105.

[260] H. Q. Hao, J. F. Zhang, Q. Q. He, et al., “Cartilage Oligomeric Matrix Protein, C-terminal Cross-linking Telopeptide of Type II Collagen, and Matrix Metalloproteinase-3 as Biomarkers for Knee and Hip Osteoarthritis (OA) Diagnosis: A Systematic Review and Meta-analysis,” Osteoarthritis and Cartilage 5 (2019): 726–736.

[261] D. Keter, V. Thai-Paquette, J. Miamidian, et al., “Synovial Fluid Dual-biomarker Algorithm Accurately Differentiates Osteoarthritis From Inflammatory Arthritis,” Journal of Orthopaedic Research 2 (2025): 304–310.

[262] P. Garnero, X. Ayral, J. C. Rousseau, et al., “Uncoupling of Type II Collagen Synthesis and Degradation Predicts Progression of Joint Damage in Patients With Knee Osteoarthritis,” Arthritis and Rheumatism 10 (2002): 2613–2624.

[263] T. Wang, H. Liu, W. Zhao, et al., “Predicting Knee Osteoarthritis Progression Using Neural Network With Longitudinal MRI Radiomics, and Biochemical Biomarkers: A Modeling Study,” Plos Medicine 8 (2025): e1004665.

[264] C. Diener, A. Keller, and E. Meese, “Emerging Concepts of miRNA Therapeutics: From Cells to Clinic,” Trends in Genetics 6 (2022): 613–626.

[265] A. Oliviero, G. Della Porta, G. M. Peretti, et al., “MicroRNA in Osteoarthritis: Physiopathology, Diagnosis and Therapeutic Challenge,” British Medical Bulletin 1 (2019): 137–147.

[266] C. Beyer, A. Zampetaki, N. Y. Lin, et al., “Signature of Circulating microRNAs in Osteoarthritis,” Annals of the Rheumatic Diseases 3 (2015): e18.

[267] E. Ntoumou, M. Tzetis, M. Braoudaki, et al., “Serum microRNA Array Analysis Identifies miR-140-3p, miR-33b-3p and miR-671-3p as Potential Osteoarthritis Biomarkers Involved in Metabolic Processes,” Clin Epigenetics 9, no. 127 (2017): 127.

[268] C. Liu, J. Gao, G. Su, et al., “MicroRNA-1202 Plays a Vital Role in Osteoarthritis via KCNQ1OT1 Has-miR-1202-ETS1 Regulatory Pathway,” Journal of Orthopaedic Surgery and Research 1 (2020): 130.

[269] M. Wei, Q. Xie, J. Zhu, et al., “MicroRNA-33 Suppresses CCL2 Expression in Chondrocytes,” Bioscience Reports 3 (2016): e00332.

[270] Y. Liu, Z. Zhang, X. Lu, et al., “Senescence-responsive miR-33-5p Promotes Chondrocyte Senescence and Osteoarthritis Progression by Targeting SIRT6,” International Immunopharmacology 121 (2023): 110506.

[271] R. Kong, J. Gao, Y. Si, et al., “Combination of Circulating miR-19b-3p, miR-122-5p and miR-486-5p Expressions Correlates With Risk and Disease Severity of Knee Osteoarthritis,” American journal of translational research 6 (2017): 2852–2864.

[272] R. Yadav, R. N. Srivastava, D. Kumar, et al., “Role of Serum Micro-RNA-122-5p Expression as a Circulatory Biomarker in People Having both Knee Osteoarthritis and Osteoporosis: A Case-Control Study,” Cureus 5 (2024): e60844.

[273] C. Pertusa, J. J. Tarin, A. Cano, et al., “Serum microRNAs in Osteoporotic Fracture and Osteoarthritis: A Genetic and Functional Study,” Scientific Reports 1 (2021): 19372.

[274] A. Fioravanti, S. Cheleschi, E. Cavalier, et al., “Can Circulating MicroRNAs, Cytokines, and Adipokines Help to Differentiate Psoriatic Arthritis From Erosive Osteoarthritis of the Hand? A Case-Control Study,” International Journal of Molecular Sciences 10 (2025): 4621.

[275] Y. Zhang, S. Xu, E. Huang, et al., “MicroRNA-130a Regulates Chondrocyte Proliferation and Alleviates Osteoarthritis Through PTEN/PI3K/Akt Signaling Pathway,” International Journal of Molecular Medicine 6 (2018): 3699–3708.

[276] Z. Zhou, F. Tian, N. An, et al., “MiR-300 Serves as Potential Biomarker to Screen Knee Osteoarthritis Patients by Targeting TNFalpha,” Clinica Y Laboratorio 4 (2018): 577–584.

[277] M. Skrzypa, D. Szala, N. Gablo, et al., “miRNA-146a-5p Is Upregulated in Serum and Cartilage Samples of Patients With Osteoarthritis,” Polski Przeglad Chirurgiczny 3 (2019): 1–5.

[278] J. C. Rousseau, M. Millet, M. Croset, et al., “Association of Circulating microRNAs With Prevalent and Incident Knee Osteoarthritis in Women: The OFELY Study,” Arthritis Research & Therapy 1 (2020): 2.

[279] L. Wan, Q. Zhao, G. Niu, et al., “Plasma miR-136 Can be Used to Screen Patients With Knee Osteoarthritis From Healthy Controls by Targeting IL-17,” Exp Ther Med 4 (2018): 3419–3424.

[280] B. Shen, S. Wang, C. Wang, et al., “Enhanced Serum miR-153-3p Promotes the Development of Knee Osteoarthritis by Targeting SOST,” Clinica Y Laboratorio 66, no. 9 (2020): 1843.

[281] C. Wang, N. Li, Q. Liu, et al., “The Role of circRNA Derived From RUNX2 in the Serum of Osteoarthritis and Its Clinical Value,” Journal of Clinical Laboratory Analysis 7 (2021): e23858.

[282] Z. Dong, H. Jiang, X. Jian, et al., “Change of miRNA Expression Profiles in Patients With Knee Osteoarthritis Before and After celecoxib Treatment,” Journal of Clinical Laboratory Analysis 1 (2019): e22648.

[283] N. Alimoradi, A. Ramezani, M. Tahami, et al., “Metformin Exhibits Anti-Inflammatory Effects by Regulating microRNA-451/CXCL16 and B Cell Leukemia/Lymphoma 2 in Patients with Osteoarthritis,” ACR Open Rheumatol 1 (2025): e11755.

[284] K. Murata, H. Yoshitomi, S. Tanida, et al., “Plasma and Synovial Fluid microRNAs as Potential Biomarkers of Rheumatoid Arthritis and Osteoarthritis,” Arthritis Research & Therapy 3 (2010): R86.

[285] Y. H. Li, G. Tavallaee, T. Tokar, et al., “Identification of Synovial Fluid microRNA Signature in Knee Osteoarthritis: Differentiating Early- and Late-stage Knee Osteoarthritis,” Osteoarthritis and Cartilage 9 (2016): 1577–1586.

[286] G. Tavallaee, S. Lively, J. S. Rockel, et al., “Contribution of MicroRNA-27b-3p to Synovial Fibrotic Responses in Knee Osteoarthritis,” Arthritis & Rheumatology 12 (2022): 1928–1942.

[287] C. Chen and H. Chen, “Clinical Diagnosis Value of miR-29b-3p in Peripheral Blood Mononuclear Cells and Synovial Fluid among Osteoarthritis Patients,” Clinica Y Laboratorio 65, no. 8 (2019): 190139.

[288] L. Rizzi, M. Turati, E. Bresciani, et al., “Characterization of microRNA Levels in Synovial Fluid From Knee Osteoarthritis and Anterior Cruciate Ligament Tears,” Biomedicines 11 (2022): 2909.

[289] R. Yang, D. Zhang, K. Yu, et al., “Detection of miR-22, miR-140 and Bone Morphogenetic Proteins (BMP)-2 Expression Levels in Synovial Fluid of Osteoarthritis Patients before and after Arthroscopic Debridement,” Medical Science Monitor 24 (2018): 863–868.

[290] C. M. Yin, W. C. Suen, S. Lin, et al., “Dysregulation of both miR-140-3p and miR-140-5p in Synovial Fluid Correlate With Osteoarthritis Severity,” Bone Joint Res 11 (2017): 612–618.

[291] Y. H. Kwak, D. K. Kwak, N. Y. Kim, et al., “Significant Changes in Synovial Fluid microRNAs After High Tibial Osteotomy in Medial Compartmental Knee Osteoarthritis: Identification of Potential Prognostic Biomarkers,” PLoS One 1 (2020): e0227596.

[292] W. Xie, W. Su, H. Xia, et al., “Synovial Fluid MicroRNA-210 as a Potential Biomarker for Early Prediction of Osteoarthritis,” BioMed research international 2019 (2019): 7165406.

[293] P. Chen, A. Ruan, J. Zhou, et al., “Identification and Analysis of Key microRNAs Derived From Osteoarthritis Synovial Fluid Exosomes,” Chin Med J (Engl) 2 (2023): 245–247.

[294] Y. Ji, L. Xiong, G. Zhang, et al., “Synovial Fluid Exosome-derived miR-182-5p Alleviates Osteoarthritis by Downregulating TNFAIP8 and Promoting Autophagy Through LC3 Signaling,” Int Immunopharmacol Pt A 125 (2023): 111177.

[295] R. Kolhe, M. Hunter, S. Liu, et al., “Gender-specific Differential Expression of Exosomal miRNA in Synovial Fluid of Patients With Osteoarthritis,” Scientific Reports 1 (2017): 2029.

[296] A. Jamshidi, O. Espin-Garcia, T. G. Wilson, et al., “MicroRNA Signature for Early Prediction of Knee Osteoarthritis Structural Progression Using Integrated Machine and Deep Learning Approaches,” Osteoarthritis and Cartilage 3 (2025): 330–340.

[297] R. K. June, R. Liu-Bryan, F. Long, et al., “Emerging Role of Metabolic Signaling in Synovial Joint Remodeling and Osteoarthritis,” Journal of Orthopaedic Research 12 (2016): 2048–2058.

[298] M. K. J. Jaggard, C. L. Boulange, G. Graca, et al., “Can Metabolic Profiling Provide a New Description of Osteoarthritis and Enable a Personalised Medicine Approach?,” Clinical Rheumatology 12 (2020): 3875–3882.

[299] X. Lin, S. He, S. Wu, et al., “Diagnostic Biomarker Panels of Osteoarthritis: UPLC-QToF/MS-based Serum Metabolic Profiling,” PeerJ 11 (2023): e14563.

[300] D. S. Kantner, E. Megill, A. Bostwick, et al., “Comparison of Colorimetric, Fluorometric, and Liquid Chromatography-mass Spectrometry Assays for Acetyl-coenzyme A,” Analytical Biochemistry 685 (2024): 115405.

[301] L. Xue, P. Schnacke, M. S. Frei, et al., “Probing Coenzyme A Homeostasis With Semisynthetic Biosensors,” Nature Chemical Biology 3 (2023): 346–355.

[302] Y. I. Shurubor, M. D'Aurelio, J. Clark-Matott, et al., “Determination of Coenzyme A and Acetyl-Coenzyme A in Biological Samples Using HPLC With UV Detection,” Molecules 9 (2017): 1388.

[303] A. I. Robby, S. Jiang, E. J. Jin, et al., “Coenzyme-A-Responsive Nanogel-Coated Electrochemical Sensor for Osteoarthritis-Detection-Based Genetic Models,” Gels 7 (2024): 451.

[304] H. Yang, J. Huang, Y. Mao, et al., “Vitexin Alleviates Interleukin-1beta-induced Inflammatory Responses in Chondrocytes From Osteoarthritis Patients: Involvement of HIF-1alpha Pathway,” Scandinavian Journal of Immunology 2 (2019): e12773.

[305] J. Fernandez-Torres, G. A. Martinez-Nava, Y. Zamudio-Cuevas, et al., “Impact of the Gene-gene Interactions Related to the HIF-1alpha Signaling Pathway With the Knee Osteoarthritis Development,” Clinical Rheumatology 10 (2019): 2897–2907.

[306] Z. Guan, X. Jin, Z. Guan, et al., “The Gut Microbiota Metabolite Capsiate Regulate SLC2A1 Expression by Targeting HIF-1alpha to Inhibit Knee Osteoarthritis-induced Ferroptosis,” Aging Cell 6 (2023): e13807.

[307] H. Chu, Z. M. Xu, H. Yu, et al., “Association Between Hypoxia-inducible Factor-1a Levels in Serum and Synovial Fluid With the Radiographic Severity of Knee Osteoarthritis,” Genetics and Molecular Research [Electronic Resource] 4 (2014): 10529–10536.

[308] L. Qing, P. Lei, H. Liu, et al., “Expression of Hypoxia-inducible Factor-1alpha in Synovial Fluid and Articular Cartilage Is Associated With Disease Severity in Knee Osteoarthritis,” Exp Ther Med 1 (2017): 63–68.

[309] F. Renaudin, K. Oudina, M. Gerbaix, et al., “NADPH Oxidase 4 Deficiency Attenuates Experimental Osteoarthritis in Mice,” RMD Open 1 (2023): e002856.

[310] S. Drevet, G. Gavazzi, L. Grange, et al., “Reactive Oxygen Species and NADPH Oxidase 4 Involvement in Osteoarthritis,” Experimental Gerontology 111 (2018): 107–117.

[311] M. J. Kim, H. J. Kim, Y. H. Hong, et al., “Age-related NADPH Oxidase (arNOX) Activity Correlated With Cartilage Degradation and Bony Changes in Age-related Osteoarthritis,” Journal of Korean Medical Science 9 (2015): 1246–1252.

[312] S. Zhou, F. Liao, and H. Wen, “Isoquercetin Alleviates Osteoarthritis via Regulating the NOX4/Nrf2 Redox Imbalance in Senescent Chondrocytes,” Int J Biol Macromol Pt 2 (2025): 141562.

[313] Q. Wang, B. Qi, S. Shi, et al., “Melatonin Alleviates Osteoarthritis by Regulating NADPH Oxidase 4-Induced Ferroptosis and Mitigating Mitochondrial Dysfunction,” Journal of Pineal Research 6 (2024): e12992.

[314] Y. F. Huang, G. Wang, L. Ding, et al., “Lactate-upregulated NADPH-dependent NOX4 Expression via HCAR1/PI3K Pathway Contributes to ROS-induced Osteoarthritis Chondrocyte Damage,” Redox Biology 67 (2023): 102867.

[315] C. R. Liao, S. N. Wang, S. Y. Zhu, et al., “Advanced Oxidation Protein Products Increase TNF-alpha and IL-1beta Expression in Chondrocytes via NADPH Oxidase 4 and Accelerate Cartilage Degeneration in Osteoarthritis Progression,” Redox Biology 28 (2020): 101306.

[316] H. Iida, M. Tani, K. Komeda, et al., “Superiority of CRP-albumin-lymphocyte Index (CALLY index) as a Non-invasive Prognostic Biomarker After Hepatectomy for Hepatocellular Carcinoma,” HPB (Oxford) 1 (2022): 101–115.

[317] S. Fu, Z. Chen, and H. Wu, “Association Between CRP-Albumin-Lymphocyte (CALLY) Index and Asthma-COPD Overlap: Analysis of NHANES 2015–2018 Data,” BMC pulmonary medicine 1 (2025): 257.

[318] T. Aoyama, Y. Maezawa, I. Hashimoto, et al., “The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment,” Anticancer Research 4 (2024): 1629–1636.

[319] J. Feng, L. Wang, X. Yang, et al., “Clinical Significance of Preoperative CALLY Index for Prognostication in Patients With Esophageal Squamous Cell Carcinoma Undergoing Surgery,” Scientific Reports 1 (2024): 713.

[320] H. Zhang, J. Shi, H. Xie, et al., “Superiority of CRP-albumin-lymphocyte Index as a Prognostic Biomarker for Patients With Gastric Cancer,” Nutrition 116 (2023): 112191.

[321] X. Y. Liu, X. Zhang, Q. Zhang, et al., “The Value of CRP-albumin-lymphocyte Index (CALLY index) as a Prognostic Biomarker in Patients With Non-small Cell Lung Cancer,” Supportive Care in Cancer 9 (2023): 533.

[322] M. Geng and K. Zhang, “CRP-Albumin-Lymphocyte Index (CALLYI) as a Risk-predicting Biomarker in Association With Osteoarthritis,” Arthritis Research & Therapy 1 (2025): 57.

[323] S. Manivong, A. Garcia-Ac, L. Mahrouche, et al., “Peptide-grafted Nanogels for Sustained Endothelin and Bradykinin Blockade in Osteoarthritis,” International Journal of Pharmaceutics 683 (2025): 126089.

[324] S. Tenti, N. A. Pascarelli, S. Cheleschi, et al., “The Emerging Role of Bradykinin in the Pathogenesis of Osteoarthritis and Its Possible Clinical Implications,” Curr Rheumatol Rev 3 (2016): 177–184.

[325] F. Bellucci, S. Meini, P. Cucchi, et al., “Synovial Fluid Levels of Bradykinin Correlate With Biochemical Markers for Cartilage Degradation and Inflammation in Knee Osteoarthritis,” Osteoarthritis and Cartilage 11 (2013): 1774–1780.

[326] F. R. Nelson, R. A. Zvirbulis, B. Zonca, et al., “The Effects of an Oral Preparation Containing Hyaluronic Acid (Oralvisc(R)) on Obese Knee Osteoarthritis Patients Determined by Pain, Function, Bradykinin, Leptin, Inflammatory Cytokines, and Heavy Water Analyses,” Rheumatology International 1 (2015): 43–52.

[327] K. Genaro and Z. D. Luo, “Pathophysiological Roles of Thrombospondin-4 in Disease Development,” Semin Cell Dev Biol Pt B 155 (2024): 66–73.

[328] S. Braun, P. Pollinger, R. Sohn, et al., “Expression of Thrombospondin-4 in the Infrapatellar Fat Pad and Synovial Fluid—potential Contribution to Osteoarthritis Pain,” Arthritis Research & Therapy 1 (2025): 170.

[329] K. Maly, I. Schaible, J. Riegger, et al., “The Expression of Thrombospondin-4 Correlates With Disease Severity in Osteoarthritic Knee Cartilage,” International Journal of Molecular Sciences 2 (2019): 447.

[330] J. P. Pelletier, J. P. Raynauld, M. Dorais, et al., “An International, Multicentre, Double-blind, Randomized Study (DISSCO): Effect of diacerein vs celecoxib on Symptoms in Knee Osteoarthritis,” Rheumatology (Oxford) 12 (2020): 3858–3868.

[331] D. E. James, J. Bailey, J. S. van der Walt, et al., “Population Pharmacokinetics and Pharmacodynamics of Fepixnebart (LY3016859) and Epiregulin in Patients With Chronic Pain,” Clinical Pharmacokinetics 5 (2025): 757–767.

[332] Y. Yazici, T. E. McAlindon, A. Gibofsky, et al., “Lorecivivint, a Novel Intraarticular CDC-Like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial,” Arthritis & Rheumatology 10 (2020): 1694–1706.

[333] C. J. Swearingen, J. R. S. Tambiah, I. Simsek, et al., “Evaluation of Safety and Efficacy of a Single Lorecivivint Injection in Patients With Knee Osteoarthritis: A Multicenter, Observational Extension Trial,” Rheumatol Ther 1 (2025): 157–171.

[334] J. Tambiah, S. Kennedy, C. Swearingen, et al., “Impact of Structural Severity on Outcomes in Knee Osteoarthritis: An Analysis of Data From Phase 2 and Phase 3 Lorecivivint Clinical Trials,” Rheumatology (Oxford) 5 (2025): 2583–2590.

[335] T. Schnitzer, M. Pueyo, H. Deckx, et al., “Evaluation of S201086/GLPG1972, an ADAMTS-5 Inhibitor, for the Treatment of Knee Osteoarthritis in ROCCELLA: A Phase 2 Randomized Clinical Trial,” Osteoarthritis and Cartilage 7 (2023): 985–994.

[336] O. Imbert, H. Deckx, K. Bernard, et al., “The Design of a Randomized, Placebo-controlled, Dose-ranging Trial to Investigate the Efficacy and Safety of the ADAMTS-5 Inhibitor S201086/GLPG1972 in Knee Osteoarthritis,” Osteoarthr Cartil Open 4 (2021): 100209.

[337] F. Brebion, R. Gosmini, P. Deprez, et al., “Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis,” Journal of Medicinal Chemistry 6 (2021): 2937–2952.

[338] G. Schett, C. Bainbridge, M. Berkowitz, et al., “Anti-granulocyte-macrophage Colony-stimulating Factor Antibody otilimab in Patients With Hand Osteoarthritis: A Phase 2a Randomised Trial,” The Lancet Rheumatology 10 (2020): e623–e632.

[339] S. J. DiMartino, H. Gao, T. Neogi, et al., “Prevalence of Preexisting Articular Bone Pathology in Patients With Osteoarthritis Screened for fasinumab Clinical Trials Identified by X-ray or Magnetic Resonance Imaging,” Osteoarthritis and Cartilage 12 (2024): 1601–1609.

[340] S. J. DiMartino, H. Gao, S. Eng, et al., “Efficacy and Safety of fasinumab in an NSAID-controlled Study in Patients With Pain due to Osteoarthritis of the Knee or Hip,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2025): 192.

[341] S. J. Russell, R. Sala, P. G. Conaghan, et al., “Triamcinolone Acetonide Extended-release in Patients With Osteoarthritis and Type 2 Diabetes: A Randomized, Phase 2 Study,” Rheumatology (Oxford) 12 (2018): 2235–2241.

[342] A. I. Spitzer, J. C. Richmond, V. B. Kraus, et al., “Safety and Efficacy of Repeat Administration of Triamcinolone Acetonide Extended-release in Osteoarthritis of the Knee: A Phase 3b, Open-label Study,” Rheumatol Ther 1 (2019): 109–124.

[343] A. Kivitz, L. Kwong, T. Shlotzhauer, et al., “A Randomized, Phase IIa Study to Assess the Systemic Exposure of Triamcinolone Acetonide Following Injection of Extended-release Triamcinolone Acetonide or Traditional Triamcinolone Acetonide Into both Knees of Patients With Bilateral Knee Osteoarthritis,” Ther Adv Musculoskelet Dis 11 (2019): 1759720×19881309.

[344] M. Iftinca, M. Defaye, and C. Altier, “TRPV1-Targeted Drugs in Development for Human Pain Conditions,” Drugs 1 (2021): 7–27.

[345] D. J. Hunter, C. C. Chang, J. C. Wei, et al., “TLC599 in Patients With Osteoarthritis of the Knee: A Phase IIa, Randomized, Placebo-controlled, Dose-finding Study,” Arthritis Research & Therapy 1 (2022): 52.

[346] T. Neogi, D. J. Hunter, M. Churchill, et al., “Observed Efficacy and Clinically Important Improvements in Participants With Osteoarthritis Treated With Subcutaneous Tanezumab: Results From a 56-week Randomized NSAID-controlled Study,” Arthritis Research & Therapy 1 (2022): 78.

[347] M. T. Brown, P. Sandroni, P. A. Low, et al., “Neurological Safety of Subcutaneous Tanezumab versus NSAID in Patients With Osteoarthritis,” Journal of the Neurological Sciences 434 (2022): 120184.

[348] J. Ren, A. G. Bushmakin, P. R. Cislo, et al., “Meaningful Within-patient Change for Clinical Outcome Assessments: Model-based Approach versus Cumulative Distribution Functions,” Journal of Biopharmaceutical Statistics 5 (2025): 826–838.

[349] T. J. Schnitzer, R. Easton, S. Pang, et al., “Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis among Patients with Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial,” Jama 1 (2019): 37–48.

[350] L. Colloca, R. H. Dworkin, J. T. Farrar, et al., “Predicting Treatment Responses in Patients with Osteoarthritis: Results from Two Phase III Tanezumab Randomized Clinical Trials,” Clinical Pharmacology & Therapeutics 4 (2023): 878–886.

[351] F. Berenbaum, R. Langford, S. Perrot, et al., “Subcutaneous tanezumab for Osteoarthritis: Is the Early Improvement in Pain and Function Meaningful and Sustained?,” European Journal of Pain 7 (2021): 1525–1539.

[352] A. Malone, M. M. Kowalski, J. Helliwell, et al., “Efficacy and Safety of a Diffusion-based Extended-release Fluticasone Propionate Intra-articular Injection (EP-104IAR) in Knee Osteoarthritis (SPRINGBOARD): A 24-week, Multicentre, Randomised, Double-blind, Vehicle-controlled, Phase 2 Trial,” The Lancet Rheumatology 12 (2024): e860–e870.

[353] T. J. Schnitzer, X. Chevalier, H. Rovsing, et al., “Intra-articular MM-II for the Treatment of Knee Osteoarthritis Pain: Efficacy and Safety Results From a 26-week, Phase 2b, Placebo-controlled, Double-blind, Randomized Dose-ranging Trial,” Osteoarthritis and Cartilage 7 (2025): 897–906.

[354] K. Mautner, M. Gottschalk, S. D. Boden, et al., “Cell-based versus Corticosteroid Injections for Knee Pain in Osteoarthritis: A Randomized Phase 3 Trial,” Nature Medicine 12 (2023): 3120–3126.

[355] P. Chatterjee, H. Y. Stevens, L. E. Kippner, et al., “Single-cell Transcriptome and Crosstalk Analysis Reveals Immune Alterations and Key Pathways in the Bone Marrow of Knee OA Patients,” Iscience 9 (2024): 110827.

[356] R. S. Schneider, E. B. Nieves, B. Aggarwal, et al., “On-chip 3D Potency Assay for Prediction of Clinical Outcomes for Cell Therapy Candidates for Osteoarthritis,” Nature Communications 1 (2025): 4915.

[357] G. A. Malanga, P. S. Chirichella, N. S. Hogaboom, et al., “Clinical Evaluation of Micro-fragmented Adipose Tissue as a Treatment Option for Patients With Meniscus Tears With Osteoarthritis: A Prospective Pilot Study,” International Orthopaedics 2 (2021): 473–480.

[358] L. Qi, Z. Li, J. Liu, et al., “Omics-Enhanced Nanomedicine for Cancer Therapy,” Advanced Materials 50 (2024): e2409102.

[359] L. Song, K. Jia, F. Yang, et al., “Advanced Nanomedicine Approaches for Myocardial Infarction Treatment,” Int J Nanomedicine 19 (2024): 6399–6425.

[360] D. Carter, M. Better, S. Abbasi, et al., “Nanomedicine for Maternal and Fetal Health,” Small 41 (2024): e2303682.

[361] J. Gupta and G. Sharma, “Nanogel: A Versatile Drug Delivery System for the Treatment of Various Diseases and Their Future Perspective,” Drug Deliv Transl Res 2 (2025): 455–482.

[362] D. Li, C. F. van Nostrum, E. Mastrobattista, et al., “Nanogels for Intracellular Delivery of Biotherapeutics,” J Control Release 259 (2017): 16–28.

[363] G. Yang, M. Fan, J. Zhu, et al., “A Multifunctional Anti-inflammatory Drug That Can Specifically Target Activated Macrophages, Massively Deplete Intracellular H(2)O(2), and Produce Large Amounts CO for a Highly Efficient Treatment of Osteoarthritis,” Biomaterials 255 (2020): 120155.

[364] T. Li, J. Yang, C. Weng, et al., “Intra-articular Injection of Anti-inflammatory Peptide-loaded Glycol Chitosan/Fucoidan Nanogels to Inhibit Inflammation and Attenuate Osteoarthritis Progression,” International Journal of Biological Macromolecules 170 (2021): 469–478.

[365] S. Nedunchezian, C. W. Wu, S. C. Wu, et al., “Characteristic and Chondrogenic Differentiation Analysis of Hybrid Hydrogels Comprised of Hyaluronic Acid Methacryloyl (HAMA), Gelatin Methacryloyl (GelMA), and the Acrylate-Functionalized Nano-Silica Crosslinker,” Polymers (Basel) 10 (2022): 2003.

[366] Y. Ma, H. Yang, X. Zong, et al., “Artificial M2 Macrophages for Disease-modifying Osteoarthritis Therapeutics,” Biomaterials 274 (2021): 120865.

[367] B. Dai, Y. Zhu, X. Li, et al., “Blockage of Osteopontin-Integrin beta3 Signaling in Infrapatellar Fat Pad Attenuates Osteoarthritis in Mice,” Advanced science (Weinheim, Baden-Wurttemberg, Germany) 22 (2023): e2300897.

[368] Y. Sun, S. L. Ding, X. Zhao, et al., “Self-Reinforced MOF-Based Nanogel Alleviates Osteoarthritis by Long-Acting Drug Release,” Advanced Materials 39 (2024): e2401094.

[369] A. Terlinden, S. Jacquet, S. Manivong, et al., “Double-blinded, Randomized Tolerance Study of a Biologically Enhanced Nanogel With Endothelin-1 and Bradykinin Receptor Antagonist Peptides via Intra-articular Injection for Osteoarthritis Treatment in Horses,” BMC Veterinary Research 1 (2024): 547.

[370] A. Cullier, F. Casse, S. Manivong, et al., “Functionalized Nanogels With Endothelin-1 and Bradykinin Receptor Antagonist Peptides Decrease Inflammatory and Cartilage Degradation Markers of Osteoarthritis in a Horse Organoid Model of Cartilage,” International Journal of Molecular Sciences 16 (2022): 8949.

[371] O. Zavgorodnya, C. A. Carmona-Moran, V. Kozlovskaya, et al., “Temperature-responsive Nanogel Multilayers of Poly(N-vinylcaprolactam) for Topical Drug Delivery,” Journal of Colloid & Interface Science 506 (2017): 589–602.

[372] J. Pan, Y. Cai, C. Zhang, et al., “Intra-articular Delivery of Geraniol Encapsulated by pH/Redox-responsive Nanogel Ameliorates Osteoarthritis by Regulating Oxidative Stress and Inflammation,” Journal of Molecular Histology 6 (2023): 579–591.

[373] C. Liu, Y. Sun, D. Li, et al., “A Multifunctional Nanogel Encapsulating Layered Double Hydroxide for Enhanced Osteoarthritis Treatment via Protection of Chondrocytes and ECM,” Mater Today Bio 26 (2024): 101034.

[374] Y. Nah, S. Sobha, G. Saravanakumar, et al., “Nitric Oxide-scavenging Hyaluronic Acid Nanoparticles for Osteoarthritis Treatment,” Biomaterials Science 6 (2024): 1477–1489.

[375] L. J. Kang, J. Yoon, J. G. Rho, et al., “Self-assembled Hyaluronic Acid Nanoparticles for Osteoarthritis Treatment,” Biomaterials 275 (2021): 120967.

[376] S. Jahanbekam, N. Mozafari, A. Bagheri-Alamooti, et al., “Ultrasound-responsive Hyaluronic Acid Hydrogel of Hydrocortisone to Treat Osteoarthritis,” International Journal of Biological Macromolecules 240 (2023): 124449.

[377] T. Zhou, J. Ran, P. Xu, et al., “A Hyaluronic Acid/Platelet-rich Plasma Hydrogel Containing MnO(2) Nanozymes Efficiently Alleviates Osteoarthritis in Vivo,” Carbohydrate Polymers 292 (2022): 119667.

[378] H. Wu, J. Wang, Y. Lin, et al., “Injectable Ozone-Rich Nanocomposite Hydrogel Loaded With D-Mannose for Anti-Inflammatory and Cartilage Protection in Osteoarthritis Treatment,” Small 25 (2024): e2309597.

[379] H. Wang, Z. Zhao, Z. Wang, et al., “Near-infrared Mo(2)Ti(2)C(3) MXene Gelatin-chitosan Hydrogels With Antioxidative, Anti-inflammation Activity for Osteoarthritis Treatment,” Int J Biol Macromol Pt 3 (2025): 141979.

[380] H. Hu, J. Yang, Y. Zhong, et al., “Polydopamine-Pd Nanozymes as Potent ROS Scavengers in Combination With near-infrared Irradiation for Osteoarthritis Treatment,” Iscience 5 (2023): 106605.

[381] Y. Li, J. Yang, X. Chen, et al., “Mitochondrial-targeting and NIR-responsive Mn(3)O(4)@PDA@Pd-SS31 Nanozymes Reduce Oxidative Stress and Reverse Mitochondrial Dysfunction to Alleviate Osteoarthritis,” Biomaterials 305 (2024): 122449.

[382] P. Mastella, B. Todaro, and S. Luin, “Nanogels: Recent Advances in Synthesis and Biomedical Applications,” Nanomaterials (Basel) 15 (2024): 1300.

[383] K. B. Narayanan, R. Bhaskar, and S. S. Han, “Recent Advances in the Biomedical Applications of Functionalized Nanogels,” Pharmaceutics 12 (2022): 2832.

[384] E. Mitsou and J. Klein, “Liposome-Based Interventions in Knee Osteoarthritis,” Small 17 (2025): e2410060.

[385] X. Ji, Y. Yan, T. Sun, et al., “Glucosamine Sulphate-loaded Distearoyl Phosphocholine Liposomes for Osteoarthritis Treatment: Combination of Sustained Drug Release and Improved Lubrication,” Biomaterials Science 7 (2019): 2716–2728.

[386] A. A. Dravid, K. M. Dhanabalan, S. Agarwal, et al., “Resolvin D1-loaded Nanoliposomes Promote M2 Macrophage Polarization and Are Effective in the Treatment of Osteoarthritis,” Bioengineering & Translational Medicine 2 (2022): e10281.

[387] U. Nedunchezhiyan, I. Varughese, A. R. Sun, et al., “Obesity, Inflammation, and Immune System in Osteoarthritis,” Frontiers in immunology 13 (2022): 907750.

[388] A. A. Dravid, K. M. Dhanabalan, S. Naskar, et al., “Sustained Release Resolvin D1 Liposomes Are Effective in the Treatment of Osteoarthritis in Obese Mice,” Journal of Biomedical Materials Research Part A 6 (2023): 765–777.

[389] Y. Zhong, Y. Zhou, R. Ding, et al., “Intra-articular Treatment of Temporomandibular Joint Osteoarthritis by Injecting Actively-loaded Meloxicam Liposomes With Dual-functions of Anti-inflammation and Lubrication,” Mater Today Bio 19 (2023): 100573.

[390] H. Teng, S. Chen, K. Fan, et al., “Dexamethasone Liposomes Alleviate Osteoarthritis in miR-204/-211-Deficient Mice by Repolarizing Synovial Macrophages to M2 Phenotypes,” Mol Pharm 8 (2023): 3843–3853.

[391] C. Deng, Y. Chen, X. Zhao, et al., “Apoptotic Neutrophil Membrane-Camouflaged Liposomes for Dually Targeting Synovial Macrophages and Fibroblasts to Attenuate Osteoarthritis,” ACS Applied Materials and Interfaces 33 (2023): 39064–39080.

[392] K. He, X. Huang, R. Shan, et al., “Intra-articular Injection of Lornoxicam and MicroRNA-140 Co-loaded Cationic Liposomes Enhanced the Therapeutic Treatment of Experimental Osteoarthritis,” Aaps Pharmscitech [Electronic Resource] 1 (2021): 9.

[393] G. Li, S. Liu, Y. Chen, et al., “An Injectable Liposome-anchored Teriparatide Incorporated Gallic Acid-grafted Gelatin Hydrogel for Osteoarthritis Treatment,” Nature Communications 1 (2023): 3159.

[394] Y. He, M. Sun, J. Wang, et al., “Chondroitin Sulfate Microspheres Anchored With Drug-loaded Liposomes Play a Dual Antioxidant Role in the Treatment of Osteoarthritis,” Acta Biomaterialia 151 (2022): 512–527.

[395] L. Zhao, L. Li, Y. Zhang, et al., “Targeting Synovial Macrophages With Astaxanthin-Loaded Liposomes for Antioxidant Treatment of Osteoarthritis,” ACS Biomaterials Science and Engineering 11 (2024): 7191–7205.

[396] L. Chen, J. Yang, Z. Cai, et al., “Mitochondrial-Oriented Injectable Hydrogel Microspheres Maintain Homeostasis of Chondrocyte Metabolism to Promote Subcellular Therapy in Osteoarthritis,” Research (Wash D C) 7 (2024): 0306.

[397] H. R. Kim, H. B. Cho, S. Lee, et al., “Fusogenic Liposomes Encapsulating Mitochondria as a Promising Delivery System for Osteoarthritis Therapy,” Biomaterials 302 (2023): 122350.

[398] A. Selvadoss, H. M. Baby, H. Zhang, et al., “Harnessing Exosomes for Advanced Osteoarthritis Therapy,” Nanoscale 41 (2024): 19174–19191.

[399] Y. Qian, G. Chu, L. Zhang, et al., “M2 macrophage-derived Exosomal miR-26b-5p Regulates macrophage Polarization and Chondrocyte Hypertrophy by Targeting TLR3 and COL10A1 to Alleviate Osteoarthritis,” J Nanobiotechnology 1 (2024): 72.

[400] C. Xu, Z. Mi, Z. Dong, et al., “Platelet-Derived Exosomes Alleviate Knee Osteoarthritis by Attenuating Cartilage Degeneration and Subchondral Bone Loss,” American Journal of Sports Medicine 11 (2023): 2975–2985.

[401] W. J. Fan, D. Liu, L. Y. Pan, et al., “Exosomes in Osteoarthritis: Updated Insights on Pathogenesis, Diagnosis, and Treatment,” Frontiers in Cell and Developmental Biology 10 (2022): 949690.

[402] M. Chen, Q. Wang, Y. Wang, et al., “Biomaterials-assisted Exosomes Therapy in Osteoarthritis,” Biomedical Materials 17, no. 2 (2022): 022001.

[403] A. Vadhan, T. Gupta, and W. L. Hsu, “Mesenchymal Stem Cell-Derived Exosomes as a Treatment Option for Osteoarthritis,” International Journal of Molecular Sciences 17 (2024): 9149.

[404] H. Yu, Y. Huang, and L. Yang, “Research Progress in the Use of Mesenchymal Stem Cells and Their Derived Exosomes in the Treatment of Osteoarthritis,” Ageing Research Reviews 80 (2022): 101684.

[405] J. Lei, X. Jiang, W. Li, et al., “Exosomes From Antler Stem Cells Alleviate Mesenchymal Stem Cell Senescence and Osteoarthritis,” Protein Cell 3 (2022): 220–226.

[406] S. Zhang, K. Y. W. Teo, S. J. Chuah, et al., “MSC Exosomes Alleviate Temporomandibular Joint Osteoarthritis by Attenuating Inflammation and Restoring Matrix Homeostasis,” Biomaterials 200 (2019): 35–47.

[407] S. Peng, C. Sun, C. Lai, et al., “Exosomes Derived From Mesenchymal Stem Cells Rescue Cartilage Injury in Osteoarthritis Through Ferroptosis by GOT1/CCR2 Expression,” International Immunopharmacology 122 (2023): 110566.

[408] S. C. Tao, T. Yuan, Y. L. Zhang, et al., “Exosomes Derived From miR-140-5p-overexpressing human Synovial Mesenchymal Stem Cells Enhance Cartilage Tissue Regeneration and Prevent Osteoarthritis of the Knee in a Rat Model,” Theranostics 1 (2017): 180–195.

[409] J. Wu, L. Kuang, C. Chen, et al., “miR-100-5p-abundant Exosomes Derived From Infrapatellar Fat Pad MSCs Protect Articular Cartilage and Ameliorate Gait Abnormalities via Inhibition of mTOR in Osteoarthritis,” Biomaterials 206 (2019): 87–100.

[410] F. X. Zhang, Y. Dou, B. Zhang, et al., “Skeletal Stem Cell-Derived Exosomes Promote Meniscal Tear Healing and Ameliorate Secondary Osteoarthritis,” American Journal of Sports Medicine 10 (2024): 2512–2523.

[411] L. He, T. He, J. Xing, et al., “Bone Marrow Mesenchymal Stem Cell-derived Exosomes Protect Cartilage Damage and Relieve Knee Osteoarthritis Pain in a Rat Model of Osteoarthritis,” Stem Cell Res Ther 1 (2020): 276.

[412] Y. Jin, M. Xu, H. Zhu, et al., “Therapeutic Effects of Bone Marrow Mesenchymal Stem Cells-derived Exosomes on Osteoarthritis,” Journal of Cellular and Molecular Medicine 19 (2021): 9281–9294.

[413] S. Zhao, G. Xiu, J. Wang, et al., “Engineering Exosomes Derived From Subcutaneous Fat MSCs Specially Promote Cartilage Repair as miR-199a-3p Delivery Vehicles in Osteoarthritis,” J Nanobiotechnology 1 (2023): 341.

[414] H. Yang, Y. Zhou, B. Ying, et al., “Effects of human Umbilical Cord Mesenchymal Stem Cell-derived Exosomes in the Rat Osteoarthritis Models,” STEM CELLS Translational Medicine 8 (2024): 803–811.

[415] J. P. Zhou, S. S. Peng, J. Xu, et al., “Exploring the Therapeutic Potential of Urine-derived Stem Cell Exosomes in Temporomandibular Joint Osteoarthritis,” Faseb Journal 15 (2024): e23852.

[416] B. Qiu, X. Xu, P. Yi, et al., “Curcumin Reinforces MSC-derived Exosomes in Attenuating Osteoarthritis via Modulating the miR-124/NF-kB and miR-143/ROCK1/TLR9 Signalling Pathways,” Journal of Cellular and Molecular Medicine 18 (2020): 10855–10865.

[417] C. Lou, H. Jiang, Z. Lin, et al., “MiR-146b-5p Enriched Bioinspired Exosomes Derived From fucoidan-directed Induction Mesenchymal Stem Cells Protect Chondrocytes in Osteoarthritis by Targeting TRAF6,” J Nanobiotechnology 1 (2023): 486.

[418] J. Wu, J. Wu, W. Xiang, et al., “Engineering Exosomes Derived From TNF-alpha Preconditioned IPFP-MSCs Enhance both Yield and Therapeutic Efficacy for Osteoarthritis,” J Nanobiotechnology 1 (2024): 555.

[419] M. Lu, A. Lou, J. Gao, et al., “Quercetin-primed MSC Exosomes Synergistically Attenuate Osteoarthritis Progression,” Journal of Orthopaedic Surgery and Research 1 (2025): 373.

[420] J. Mondal, S. Pillarisetti, V. Junnuthula, et al., “Hybrid Exosomes, Exosome-Like Nanovesicles and Engineered Exosomes for Therapeutic Applications,” J Control Release 353 (2023): 1127–1149.

[421] Y. Liang, L. Duan, J. Lu, et al., “Engineering Exosomes for Targeted Drug Delivery,” Theranostics 7 (2021): 3183–3195.

[422] M. H. Fan, J. K. Pi, C. Y. Zou, et al., “Hydrogel-exosome System in Tissue Engineering: A Promising Therapeutic Strategy,” Bioactive Materials 38 (2024): 1–30.

[423] Y. Zhang, X. Wang, J. Chen, et al., “Exosomes Derived From Platelet-rich Plasma Administration in Site Mediate Cartilage Protection in Subtalar Osteoarthritis,” J Nanobiotechnology 1 (2022): 56.

[424] H. Cao, M. Chen, X. Cui, et al., “Cell-Free Osteoarthritis Treatment With Sustained-Release of Chondrocyte-Targeting Exosomes From Umbilical Cord-Derived Mesenchymal Stem Cells to Rejuvenate Aging Chondrocytes,” ACS Nano 14 (2023): 13358–13376.

[425] J. Wan, Z. He, R. Peng, et al., “Injectable Photocrosslinking Spherical Hydrogel-encapsulated Targeting Peptide-modified Engineered Exosomes for Osteoarthritis Therapy,” J Nanobiotechnology 1 (2023): 284.

[426] L. Yang, W. Li, Y. Zhao, et al., “Magnetic Polysaccharide Mesenchymal Stem Cells Exosomes Delivery Microcarriers for Synergistic Therapy of Osteoarthritis,” ACS Nano 18, no. 31 (2024): 20101–20110.

[427] T. Ma, G. Xu, T. Gao, et al., “Engineered Exosomes With ATF5-Modified mRNA Loaded in Injectable Thermogels Alleviate Osteoarthritis by Targeting the Mitochondrial Unfolded Protein Response,” ACS Applied Materials & Interfaces 17 (2024): 21383–21399.

[428] H. Cao, W. Li, H. Zhang, et al., “Bio-nanoparticles Loaded With Synovial-derived Exosomes Ameliorate Osteoarthritis Progression by Modifying the Oxidative Microenvironment,” J Nanobiotechnology 1 (2024): 271.

[429] Y. Liang, X. Xu, L. Xu, et al., “Chondrocyte-specific Genomic Editing Enabled by Hybrid Exosomes for Osteoarthritis Treatment,” Theranostics 11 (2022): 4866–4878.

[430] M. Chen, Y. Lu, Y. Liu, et al., “Injectable Microgels With Hybrid Exosomes of Chondrocyte-Targeted FGF18 Gene-Editing and Self-Renewable Lubrication for Osteoarthritis Therapy,” Advanced Materials 16 (2024): e2312559.

[431] Y. Liang, X. Xu, X. Li, et al., “Chondrocyte-Targeted MicroRNA Delivery by Engineered Exosomes Toward a Cell-Free Osteoarthritis Therapy,” ACS Applied Materials & Interfaces 33 (2020): 36938–36947.

[432] C. Zhang, T. V. Pathrikar, H. M. Baby, et al., “Charge-Reversed Exosomes for Targeted Gene Delivery to Cartilage for Osteoarthritis Treatment,” Small Methods 9 (2024): e2301443.

[433] H. M. Okuyan, A. Coskun, and M. A. Begen, “Current Status, Opportunities, and Challenges of Exosomes in Diagnosis and Treatment of Osteoarthritis,” Life Sciences 362 (2025): 123365.

[434] C. Y. Liu, Y. S. Duan, H. Zhou, et al., “Clinical Effect and Contributing Factors of Acupuncture for Knee Osteoarthritis: A Systematic Review and Pairwise and Exploratory Network Meta-analysis,” BMJ Evid Based Med 6 (2024): 374–384.

[435] H. Chen, H. Shi, S. Gao, et al., “Durable Effects of Acupuncture for Knee Osteoarthritis: A Systematic Review and Meta-analysis,” Current Pain and Headache Reports 7 (2024): 709–722.

[436] J. F. Tu, J. W. Yang, G. X. Shi, et al., “Efficacy of Intensive Acupuncture versus Sham Acupuncture in Knee Osteoarthritis: A Randomized Controlled Trial,” Arthritis & Rheumatology 3 (2021): 448–458.

[437] L. L. Lin, J. F. Tu, L. Q. Wang, et al., “Acupuncture of Different Treatment Frequencies in Knee Osteoarthritis: A Pilot Randomised Controlled Trial,” Pain 11 (2020): 2532–2538.

[438] Z. B. Kalkhoran and R. Khanmohammadi, “The Effects of Aquatic Therapy Combined With Transcranial Direct Current Stimulation (tDCS) on Proprioception and Gait Speed in Older Adults With Knee Osteoarthritis: An Eight-week Randomized Sham-controlled Trial,” BMC Geriatr 1 (2025): 676.

[439] Q. Nie, F. He, L. Dong, et al., “Effects of Transcranial Direct Current Stimulation Combined With Acupuncture Therapy on Brain Network Functional Connectivity in Patients With Knee Osteoarthritis: A Single-center Randomized Controlled Trial,” J Neuroeng Rehabil 1 (2025): 160.

[440] Y. L. Wu, Y. Luo, J. M. Yang, et al., “Effects of Transcranial Direct Current Stimulation on Pain and Physical Function in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2024): 703.

[441] F. Rahimi, M. Sadeghisani, and A. Karimzadeh, “Efficacy of Transcranial Direct Current Stimulation in Patients With Knee Osteoarthritis: A Systematic Review,” Neurophysiologie Clinique = Clinical Neurophysiology 6 (2023): 102918.

[442] J. M. Yang, C. C. Li, Y. Wang, et al., “Transcranial Direct Current Stimulation for Knee Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,” Arthritis Care Res (Hoboken) 3 (2024): 376–384.

[443] Q. Li, Y. Hou, P. Cao, et al., “Near-Infrared Light-Activated Mesoporous Polydopamine for Temporomandibular Joint Osteoarthritis Combined Photothermal-Chemo Therapy,” International Journal of Molecular Sciences 10 (2023): 9055.

[444] Z. Usman, S. S. Maharaj, and B. Kaka, “Effects of Combination Therapy and Infrared Radiation on Pain, Physical Function, and Quality of Life in Subjects With Knee Osteoarthritis: A Randomized Controlled Study,” Hong Kong Physiother J 2 (2019): 133–142.

[445] R. L. Hsieh, M. T. Lo, W. C. Lee, et al., “Therapeutic Effects of Short-term Monochromatic Infrared Energy Therapy on Patients With Knee Osteoarthritis: A Double-blind, Randomized, Placebo-controlled Study,” Journal of Orthopaedic and Sports Physical Therapy 11 (2012): 947–956.

[446] M. A. Ahmad, A. H. MS, and A. Yusof, “Effects of Low-level and High-intensity Laser Therapy as Adjunctive to Rehabilitation Exercise on Pain, Stiffness and Function in Knee Osteoarthritis: A Systematic Review and Meta-analysis,” Physiotherapy 114 (2022): 85–95.

[447] L. Zhao, K. Cheng, F. Wu, et al., “Effect of Laser Moxibustion for Knee Osteoarthritis: A Multisite, Double-blind Randomized Controlled Trial,” Journal of Rheumatology 6 (2021): 924–932.

[448] M. B. Stausholm, I. F. Naterstad, J. Joensen, et al., “Efficacy of Low-level Laser Therapy on Pain and Disability in Knee Osteoarthritis: Systematic Review and Meta-analysis of Randomised Placebo-controlled Trials,” BMJ Open 10 (2019): e031142.

[449] A. R. Paolillo, F. R. Paolillo, J. P. Joao, et al., “Synergic Effects of Ultrasound and Laser on the Pain Relief in Women With Hand Osteoarthritis,” Lasers in Medical Science 1 (2015): 279–286.

[450] A. Cp, K. Jayaraman, R. A. Babkair, et al., “Effectiveness of Extracorporeal Shock Wave Therapy on Functional Ability in Grade IV Knee Osteoarthritis—a Randomized Controlled Trial,” Scientific Reports 1 (2024): 16530.

[451] P. Tang, T. Wen, W. Lu, et al., “The Efficacy of Extracorporeal Shock Wave Therapy for Knee Osteoarthritis: An Umbrella Review,” Int J Surg 4 (2024): 2389–2395.

[452] L. Jia, D. Li, X. Wei, et al., “Efficacy and Safety of Focused Low-intensity Pulsed Ultrasound versus Pulsed Shortwave Diathermy on Knee Osteoarthritis: A Randomized Comparative Trial,” Scientific Reports 1 (2022): 12792.

[453] M. Mostafa, H. A. Hamada, A. M. Kadry, et al., “Effect of High-Power Laser Therapy versus Shock Wave Therapy on Pain and Function in Knee Osteoarthritis Patients: A Randomized Controlled Trial,” Photobiomodul Photomed Laser Surg 3 (2022): 198–204.

[454] L. Chen, L. Ye, H. Liu, et al., “Extracorporeal Shock Wave Therapy for the Treatment of Osteoarthritis: A Systematic Review and Meta-Analysis,” BioMed research international 2020 (2020): 1907821.

[455] Q. Luo, R. Zhang, Z. Liang, et al., “Ultrasound Therapy Inhibits Knee Osteoarthritis Progression in Rabbits by Activating the PPARs Pathway: A Pilot Study,” Annals of Medicine 1 (2025): 2537348.

[456] Y. Liu, Y. Wang, Y. Wang, et al., “A Meta-Analysis of Analgesic Effect of Ultrasound Therapy for Patients with Knee Osteoarthritis,” Journal of Ultrasound in Medicine 8 (2022): 1861–1872.

[457] L. O. Dantas, M. C. Osani, and R. R. Bannuru, “Therapeutic Ultrasound for Knee Osteoarthritis: A Systematic Review and Meta-analysis With Grade Quality Assessment,” Braz J Phys Ther 6 (2021): 688–697.

[458] R. A. Ungur, V. M. Ciortea, L. Irsay, et al., “Can Ultrasound Therapy Be an Environmental-Friendly Alternative to Non-Steroidal Anti-Inflammatory Drugs in Knee Osteoarthritis Treatment?,” Materials (Basel) 11 (2021): 2715.

[459] M. Kiraly, E. Gomori, R. Kiss, et al., “Effects of Various Types of Ultrasound Therapy in Hip Osteoarthritis—a Double-blind, Randomized, Controlled, Follow-up Study,” Physiother Theory Pract 12 (2022): 1958–1968.

[460] Y. Wu, S. Zhu, Z. Lv, et al., “Effects of Therapeutic Ultrasound for Knee Osteoarthritis: A Systematic Review and Meta-analysis,” Clinical Rehabilitation 12 (2019): 1863–1875.

[461] Z. Guo, X. Wang, Y. Zhou, et al., “Effect of Shujin Xiaotong Capsules Combined With Ultrashort Wave Therapy on Pain and Inflammatory Cytokines in Patients With Chronic Knee Osteoarthritis,” American journal of translational research 7 (2021): 8085–8093.

[462] R. K. Nelligan, R. S. Hinman, J. Kasza, et al., “Effects of a Self-directed Web-Based Strengthening Exercise and Physical Activity Program Supported by Automated Text Messages for People with Knee Osteoarthritis: A Randomized Clinical Trial,” JAMA Internal Medicine 6 (2021): 776–785.

[463] H. Larkin, “Both High- and Low-Dose Exercise Therapy Help Knee Osteoarthritis,” Jama 7 (2023): 532.

[464] Q. Weng, S. L. Goh, J. Wu, et al., “Comparative Efficacy of Exercise Therapy and Oral Non-steroidal Anti-inflammatory Drugs and Paracetamol for Knee or Hip Osteoarthritis: A Network Meta-analysis of Randomised Controlled Trials,” British Journal of Sports Medicine 15 (2023): 990–996.

[465] S. Su, C. C. Yu, E. F. Zhou, et al., “Effect of Aerobic Exercise on Cardiopulmonary Fitness Among People With Knee Osteoarthritis: A Systematic Review and Meta-analysis,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2025): 549.

[466] B. J. Lawford, M. Hall, R. S. Hinman, et al., “Exercise for Osteoarthritis of the Knee,” Cochrane Database of Systematic Reviews 12 (2024): CD004376.

[467] W. F. Gomes, A. C. Lacerda, G. E. Brito-Melo, et al., “Aerobic Training Modulates T Cell Activation in Elderly Women With Knee Osteoarthritis,” Brazilian Journal of Medical and Biological Research 11 (2016): e5181.

[468] F. Kilic, A. Demirguc, S. A. Arslan, et al., “The Effect of Aerobic Exercise Training on Postmenopausal Patients With Knee Osteoarthritis,” J Back Musculoskelet Rehabil 6 (2020): 995–1002.

[469] G. H. Lo, S. Vinod, M. J. Richard, et al., “Association between Walking for Exercise and Symptomatic and Structural Progression in Individuals with Knee Osteoarthritis: Data from the Osteoarthritis Initiative Cohort,” Arthritis & Rheumatology 10 (2022): 1660–1667.

[470] A. H. Alghadir, S. Anwer, B. Sarkar, et al., “Effect of 6-week Retro or Forward Walking Program on Pain, Functional Disability, Quadriceps Muscle Strength, and Performance in Individuals With Knee Osteoarthritis: A Randomized Controlled Trial (retro-walking trial),” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2019): 159.

[471] Z. Xu, Y. Wang, Y. Zhang, et al., “Efficacy and Safety of Aquatic Exercise in Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials,” Clinical Rehabilitation 3 (2023): 330–347.

[472] L. Luan, J. Bousie, A. Pranata, et al., “Stationary Cycling Exercise for Knee Osteoarthritis: A Systematic Review and Meta-analysis,” Clinical Rehabilitation 4 (2021): 522–533.

[473] J. Multanen, T. Rantalainen, H. Kautiainen, et al., “Effect of Progressive High-impact Exercise on Femoral Neck Structural Strength in Postmenopausal Women With Mild Knee Osteoarthritis: A 12-month RCT,” Osteoporosis International 4 (2017): 1323–1333.

[474] J. Multanen, M. T. Nieminen, A. Hakkinen, et al., “Effects of High-impact Training on Bone and Articular Cartilage: 12-month Randomized Controlled Quantitative MRI Study,” Journal of Bone and Mineral Research 1 (2014): 192–201.

[475] J. W. Keogh, J. Grigg, and C. J. Vertullo, “Is High-intensity Interval Cycling Feasible and More Beneficial Than Continuous Cycling for Knee Osteoarthritic Patients? Results of a Randomised Control Feasibility Trial,” PeerJ 6 (2018): e4738.

[476] J. W. L. Keogh, J. Grigg, and C. J. Vertullo, “Is Home-Based, High-Intensity Interval Training Cycling Feasible and Safe for Patients with Knee Osteoarthritis?: Study Protocol for a Randomized Pilot Study,” Orthop J Sports Med 3 (2017): 2325967117694334.

[477] C. Su, L. Huang, S. Tu, et al., “Different Intensities of Aerobic Training for Patients With Type 2 Diabetes Mellitus and Knee Osteoarthritis: A Randomized Controlled Trial,” Front Endocrinol (Lausanne) 15 (2024): 1463587.

[478] T. A. Torstensen, H. Osteras, R. LoMartire, et al., “High- Versus Low-Dose Exercise Therapy for Knee Osteoarthritis: A Randomized Controlled Multicenter Trial,” Annals of Internal Medicine 2 (2023): 154–165.

[479] Y. Li, Y. Su, S. Chen, et al., “The Effects of Resistance Exercise in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis,” Clinical Rehabilitation 10 (2016): 947–959.

[480] H. Chen, X. Zheng, H. Huang, et al., “The Effects of a Home-based Exercise Intervention on Elderly Patients With Knee Osteoarthritis: A Quasi-experimental Study,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2019): 160.

[481] B. E. Oiestad, A. Aroen, J. H. Rotterud, et al., “The Efficacy of Strength or Aerobic Exercise on Quality of Life and Knee Function in Patients With Knee Osteoarthritis. A Multi-arm Randomized Controlled Trial With 1-year Follow-up,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2023): 714.

[482] B. J. Abafita, A. Singh, D. Aitken, et al., “Yoga or Strengthening Exercise for Knee Osteoarthritis: A Randomized Clinical Trial,” JAMA Network Open 4 (2025): e253698.

[483] L. Ceballos-Laita, S. Lahuerta-Martin, A. Carrasco-Uribarren, et al., “Strength Training vs. Aerobic Training for Managing Pain and Physical Function in Patients With Knee Osteoarthritis: A Systematic Review and Meta-Analysis,” Healthcare (Basel) 1 (2023): 33.

[484] K. R. Vincent, T. Vasilopoulos, C. Montero, et al., “Eccentric and Concentric Resistance Exercise Comparison for Knee Osteoarthritis,” Medicine and Science in Sports and Exercise 10 (2019): 1977–1986.

[485] H. Tanaka, T. Ikezoe, M. Nakamura, et al., “Improvement in Muscle Strength With Low-load Isotonic Training Depends on Fascicle Length but Not Joint Angle,” Muscle & Nerve 1 (2018): 83–89.

[486] S. P. Messier, S. L. Mihalko, D. P. Beavers, et al., “Effect of High-Intensity Strength Training on Knee Pain and Knee Joint Compressive Forces among Adults with Knee Osteoarthritis: The START Randomized Clinical Trial,” Jama 7 (2021): 646–657.

[487] B. Bregenhof, P. Aagaard, N. Nissen, et al., “The Effect of Progressive Resistance Exercise on Knee Muscle Strength and Function in Participants With Persistent Hamstring Deficit Following ACL Reconstruction: A Randomized Controlled Trial,” Journal of Orthopaedic and Sports Physical Therapy 1 (2023): 40–48.

[488] L. P. Dos Santos, R. Santo, T. R. Ramis, et al., “The Effects of Resistance Training With Blood Flow Restriction on Muscle Strength, Muscle Hypertrophy and Functionality in Patients With Osteoarthritis and Rheumatoid Arthritis: A Systematic Review With Meta-analysis,” PLoS One 11 (2021): e0259574.

[489] E. Jacobs, L. Stroobant, J. Victor, et al., “Vascular Occlusion for Optimising the Functional Improvement in Patients With Knee Osteoarthritis: A Randomised Controlled Trial,” Annals of the Rheumatic Diseases 2 (2025): 341–350.

[490] A. Franz, S. Ji, B. Bittersohl, et al., “Impact of a Six-Week Prehabilitation with Blood-Flow Restriction Training on Pre- and Postoperative Skeletal Muscle Mass and Strength in Patients Receiving Primary Total Knee Arthroplasty,” Front Physiol 13 (2022): 881484.

[491] S. L. Jorgensen, P. Aagaard, M. B. Bohn, et al., “The Effect of Blood Flow Restriction Exercise Prior to Total Knee Arthroplasty on Postoperative Physical Function, Lower Limb Strength and Patient-Reported Outcomes: A Randomized Controlled Trial,” Scandinavian Journal of Medicine & Science in Sports 11 (2024): e14750.

[492] R. M. Killingmo, B. E. Oiestad, M. A. Risberg, et al., “Cost-effectiveness of Strength Exercise or Aerobic Exercise Compared With Usual Care for Patients With Knee Osteoarthritis: Secondary Results From a Multiarm Randomised Controlled Trial in Norway,” BMJ Open 5 (2024): e079704.

[493] C. A. Primeau, T. B. Birmingham, R. F. Moyer, et al., “Trajectories of Perceived Exertion and Pain Over a 12-week Neuromuscular Exercise Program in Patients With Knee Osteoarthritis,” Osteoarthritis and Cartilage 11 (2020): 1427–1431.

[494] E. M. Roos, S. Kroman, and E. Ageberg, “An Exercise Therapists' Guide to Neuromuscular Exercise for People with Knee or Hip Osteoarthritis,” Journal of Orthopaedic and Sports Physical Therapy 8 (2025): 1–9.

[495] A. Holsgaard-Larsen, B. Clausen, J. Sondergaard, et al., “The Effect of Instruction in Analgesic Use Compared With Neuromuscular Exercise on Knee-joint Load in Patients With Knee Osteoarthritis: A Randomized, Single-blind, Controlled Trial,” Osteoarthritis and Cartilage 4 (2017): 470–480.

[496] A. Holsgaard-Larsen, R. Christensen, B. Clausen, et al., “One Year Effectiveness of Neuromuscular Exercise Compared With Instruction in Analgesic Use on Knee Function in Patients With Early Knee Osteoarthritis: The EXERPHARMA Randomized Trial,” Osteoarthritis and Cartilage 1 (2018): 28–33.

[497] X. Yang, H. Song, X. Li, et al., “Neuromuscular Exercise in Addition to celecoxib versus celecoxib Alone for Symptomatic and Radiographic Knee Osteoarthritis: A Randomized Controlled Trial,” BMC Sports Sci Med Rehabil 1 (2025): 213.

[498] T. Kjeldsen, U. Dalgas, S. T. Skou, et al., “Booster Sessions for Maintaining the Effect of Neuromuscular Exercise and Progressive Resistance Training in Hip Osteoarthritis: 12-month Follow-up From a Multicenter Cluster-randomized Controlled Trial,” Osteoarthritis and Cartilage 11 (2025): 1393–1403.

[499] T. Kjeldsen, S. T. Skou, U. Dalgas, et al., “Progressive Resistance Training or Neuromuscular Exercise for Hip Osteoarthritis: A Multicenter Cluster Randomized Controlled Trial,” Annals of Internal Medicine 5 (2024): 573–582.

[500] N. Anjum, R. K. Sheikh, A. Omer, et al., “Comparison of Instrument-assisted Soft Tissue Mobilization and Proprioceptive Neuromuscular Stretching on Hamstring Flexibility in Patients With Knee Osteoarthritis,” PeerJ 11 (2023): e16506.

[501] S. S. Harby, M. M. El-Sayed, A. M. El-Ashry, et al., “Evaluating the Impact of a Nursing-Led Neuromuscular Exercise Program on Pain, Range of Motion, and Quality of Life in Knee Osteoarthritis Patients: A Quasi-Experimental Approach,” Nursing & Health Sciences 2 (2025): e70120.

[502] E. Ageberg, A. Nilsdotter, E. Kosek, et al., “Effects of Neuromuscular Training (NEMEX-TJR) on Patient-reported Outcomes and Physical Function in Severe Primary Hip or Knee Osteoarthritis: A Controlled Before-and-After Study,” BMC Musculoskeletal Disorders [Electronic Resource] 14 (2013): 232.

[503] L. Fernandes, E. M. Roos, S. Overgaard, et al., “Supervised Neuromuscular Exercise Prior to Hip and Knee Replacement: 12-month Clinical Effect and Cost-utility Analysis alongside a Randomised Controlled Trial,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2017): 5.

[504] A. M. Risso, M. L. van der Linden, A. Bailey, et al., “Exploratory Insights Into Novel Prehabilitative Neuromuscular Exercise-conditioning in Total Knee Arthroplasty,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2022): 547.

[505] N. Markopoulos, T. Apostolou, I. Kallistratos, et al., “Effect of Proprioceptive Neuromuscular Facilitation and Focal Vibration in Older Adults With Osteoarthritis After Total Knee Arthroplasty: A Randomized Clinical Trial Study,” J Back Musculoskelet Rehabil 3 (2025): 550–566.

[506] Z. P. Zeng, Y. B. Liu, J. Fang, et al., “Effects of Baduanjin Exercise for Knee Osteoarthritis: A Systematic Review and Meta-analysis,” Complementary Therapies in Medicine 48 (2020): 102279.

[507] Y. Xie, F. Guo, Y. Lu, et al., “A 12-week Baduanjin Qigong Exercise Improves Symptoms of Ankylosing Spondylitis: A Randomized Controlled Trial,” Complement Ther Clin Pract 36 (2019): 113–119.

[508] Y. Tian, Z. Y. Liu, J. H. Wang, et al., “The Efficacy and Safety of Baduanjin Exercise as Complementary Therapy for Pain Reduction and Functional Improvement in Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials,” Complementary Therapies in Medicine 88 (2025): 103127.

[509] F. Wang, X. Zhang, X. Tong, et al., “The Effects on Pain, Physical Function, and Quality of Life of Quadriceps Strengthening Exercises Combined With Baduanjin qigong in Older Adults With Knee Osteoarthritis: A Quasi-experimental Study,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2021): 313.

[510] J. Liu, L. Chen, X. Chen, et al., “Modulatory Effects of Different Exercise Modalities on the Functional Connectivity of the Periaqueductal Grey and Ventral Tegmental Area in Patients With Knee Osteoarthritis: A Randomised Multimodal Magnetic Resonance Imaging Study,” British Journal of Anaesthesia 4 (2019): 506–518.

[511] J. Liu, L. Chen, Y. Tu, et al., “Different Exercise Modalities Relieve Pain Syndrome in Patients With Knee Osteoarthritis and Modulate the Dorsolateral Prefrontal Cortex: A Multiple Mode MRI Study,” Brain, Behavior, and Immunity 82 (2019): 253–263.

[512] Y. Ye and A. Liu, “The Effectiveness of Tai Chi for Knee Osteoarthritis: An Overview of Systematic Reviews,” Int J Gen Med 16 (2023): 4499–4514.

[513] K. K. Ho, G. Pong, Q. W. Poon, et al., “A Community-centric Multi-disciplinary Education Program With the 8-section Brocade Tai Chi Therapy for Patients With Osteoarthritis of the Knee—a Pilot Study,” BMC Complement Med Ther 1 (2021): 297.

[514] A. Zhao, W. J. Brown, J. S. Coombes, et al., “The Effects of Tai Chi on Pain and Other Health Indicators in People With Osteoarthritis: An Updated Systematic Review and Dose-response Meta-analysis,” Osteoarthritis and Cartilage 8 (2025): 933–950.

[515] A. C. Lee, W. F. Harvey, L. L. Price, et al., “Dose-Response Effects of Tai Chi and Physical Therapy Exercise Interventions in Symptomatic Knee Osteoarthritis,” PM R 7 (2018): 712–723.

[516] Z. Zhang, L. Huang, Y. Liu, et al., “Effect of Tai Chi Training on Plantar Loads During Walking in Individuals With Knee Osteoarthritis,” BioMed research international 2020 (2020): 3096237.

[517] Y. You, J. Liu, M. Tang, et al., “Effects of Tai Chi Exercise on Improving Walking Function and Posture Control in Elderly Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis,” Medicine (Baltimore) 16 (2021): e25655.

[518] X. Hu, Z. Lai, and L. Wang, “Effects of Taichi Exercise on Knee and Ankle Proprioception Among Individuals With Knee Osteoarthritis,” Res Sports Med 2 (2020): 268–278.

[519] E. Ghandali, S. T. Moghadam, M. R. Hadian, et al., “The Effect of Tai Chi Exercises on Postural Stability and Control in Older Patients With Knee Osteoarthritis,” J Bodyw Mov Ther 3 (2017): 594–598.

[520] J. Pan, Z. Xie, S. Ye, et al., “The Effects of Tai Chi on Clinical Outcomes and Gait Biomechanics in Knee Osteoarthritis Patients: A Pilot Randomized Controlled Trial,” Scientific Reports 1 (2025): 18495.

[521] N. Zhang, H. Cui, H. Li, et al., “Effects of Tai Chi in Knee Osteoarthritis Patients: An Overview of Systematic Reviews and Meta-analyses,” Complementary Therapies in Medicine 77 (2023): 102978.

[522] L. Hu, Y. Wang, X. Liu, et al., “Tai Chi Exercise Can Ameliorate Physical and Mental Health of Patients With Knee Osteoarthritis: Systematic Review and Meta-analysis,” Clinical Rehabilitation 1 (2021): 64–79.

[523] C. L. Shen, J. W. Newman, M. M. Elmassry, et al., “Tai Chi Exercise Reduces Circulating Levels of Inflammatory Oxylipins in Postmenopausal Women With Knee Osteoarthritis: Results From a Pilot Study,” Front Med (Lausanne) 10 (2023): 1210170.

[524] C. L. Shen, B. A. Watkins, C. Kahathuduwa, et al., “Tai Chi Improves Brain Functional Connectivity and Plasma Lysophosphatidylcholines in Postmenopausal Women with Knee Osteoarthritis: An Exploratory Pilot Study,” Front Med (Lausanne) 8 (2021): 775344.

[525] T. Tao, M. P. Shi, X. S. Zhang, et al., “Effects of Different Traditional Chinese Exercise for Knee Osteoarthritis Patients: A Network Meta-analysis of Randomized Controlled Trials,” Medicine (Baltimore) 38 (2024): e39660.

[526] M. Lv, J. Wang, X. Chu, et al., “Effect of Traditional Chinese Exercises on Knee Osteoarthritis: A Network Meta-analysis,” J Back Musculoskelet Rehabil 1 (2025): 48–62.

[527] K. L. Bennell, B. J. Lawford, C. Keating, et al., “Comparing Video-Based, Telehealth-Delivered Exercise and Weight Loss Programs with Online Education on Outcomes of Knee Osteoarthritis: A Randomized Trial,” Annals of Internal Medicine 2 (2022): 198–209.

[528] V. Dieter, P. Janssen, and I. Krauss, “Efficacy of the mHealth-Based Exercise Intervention re.flex for Patients with Knee Osteoarthritis: Pilot Randomized Controlled Trial,” JMIR Mhealth Uhealth 12 (2024): e54356.

[529] J. Long, J. You, and Y. Yang, “Effect of Digital Exercise Therapy on the Pain and Physical Function of Patients with Osteoarthritis: Systematic Review and Meta-Analysis,” Journal of Medical Internet Research [Electronic Resource] 27 (2025): e66037.

[530] S. J. Zhu, K. L. Bennell, R. S. Hinman, et al., “Development of a 12-Week Unsupervised Online Tai Chi Program for People with Hip and Knee Osteoarthritis: Mixed Methods Study,” JMIR Aging 7 (2024): e55322.

[531] S. Han, T. Li, Y. Cao, et al., “Quantitative Analysis of Effectiveness and Associated Factors of Exercise on Symptoms in Osteoarthritis: A Pharmacodynamic Model-based Meta-analysis,” British Journal of Sports Medicine 24 (2024): 1539–1550.

[532] E. C. Bell, J. A. Wallis, A. J. Goff, et al., “Does Land-based Exercise-therapy Improve Physical Activity in People With Knee Osteoarthritis? A Systematic Review With Meta-analyses,” Osteoarthritis and Cartilage 11 (2022): 1420–1433.

[533] M. A. Holden, M. Hattle, J. Runhaar, et al., “Moderators of the Effect of Therapeutic Exercise for Knee and Hip Osteoarthritis: A Systematic Review and Individual Participant Data Meta-analysis,” The Lancet Rheumatology 7 (2023): e386–e400.

[534] T. Beauchamp, L. Arbeeva, R. J. Cleveland, et al., “Accelerometer-Based Physical Activity Patterns and Associations with Outcomes among Individuals with Osteoarthritis,” J Clin Rheumatol 2 (2022): e415–e421.

[535] K. Allen, M. B. Vu, L. F. Callahan, et al., “Osteoarthritis Physical Activity Care Pathway (OA-PCP): Results of a Feasibility Trial,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2020): 308.

[536] C. J. Dharmasri, I. Griesemer, L. Arbeeva, et al., “Acceptability of Telephone-based Pain Coping Skills Training Among African Americans With Osteoarthritis Enrolled in a Randomized Controlled Trial: A Mixed Methods Analysis,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2020): 545.

[537] K. D. Allen, L. Arbeeva, C. W. Cene, et al., “Pain Coping Skills Training for African Americans With Osteoarthritis Study: Baseline Participant Characteristics and Comparison to Prior Studies,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2018): 337.

[538] L. A. Schrubbe, S. G. Ravyts, B. C. Benas, et al., “Pain Coping Skills Training for African Americans With Osteoarthritis (STAART): Study Protocol of a Randomized Controlled Trial,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2016): 359.

[539] M. A. Boswell, K. M. Evans, D. Ghandwani, et al., “A Randomized Clinical Trial Testing Digital Mindset Intervention for Knee Osteoarthritis Pain and Activity Improvement,” NPJ Digit Med 1 (2024): 285.

[540] J. N. Chopp-Hurley, E. C. Brenneman, E. G. Wiebenga, et al., “Randomized Controlled Trial Investigating the Role of Exercise in the Workplace to Improve Work Ability, Performance, and Patient-Reported Symptoms among Older Workers with Osteoarthritis,” Journal of Occupational and Environmental Medicine 6 (2017): 550–556.

[541] S. P. Messier, M. E. Gill, S. L. Mihalko, et al., “Clinical, Health-Related Quality of Life, and Gait Differences among Obesity Classes in Adults with Knee Osteoarthritis,” Arthritis Care Res (Hoboken) 4 (2024): 503–510.

[542] S. P. Messier, L. F. Callahan, D. P. Beavers, et al., “Weight-loss and Exercise for Communities With Arthritis in North Carolina (we-can): Design and Rationale of a Pragmatic, Assessor-blinded, Randomized Controlled Trial,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2017): 91.

[543] B. G. Kaufman, K. D. Allen, C. J. Coffman, et al., “Cost and Quality of Life Outcomes of the STepped Exercise Program for Patients with Knee OsteoArthritis Trial,” Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research 4 (2022): 614–621.

[544] K. D. Allen, S. Woolson, H. M. Hoenig, et al., “Stepped Exercise Program for Patients with Knee Osteoarthritis: A Randomized Controlled Trial,” Annals of Internal Medicine 3 (2021): 298–307.

[545] K. D. Allen, D. Bongiorni, K. Caves, et al., “STepped Exercise Program for Patients With Knee OsteoArthritis (STEP-KOA): Protocol for a Randomized Controlled Trial,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2019): 254.

[546] J. B. Aily, J. Copson, D. Voinier, et al., “Understanding Recruitment Yield from Social Media Advertisements and Associated Costs of a Telehealth Randomized Controlled Trial: Descriptive Study,” Journal of Medical Internet Research [Electronic Resource] 25 (2023): e41358.

[547] J. T. Jakiela, D. Voinier, R. S. Hinman, et al., “Comparing an Expanded versus Brief Telehealth Physical Therapist Intervention for Knee Osteoarthritis: Study Protocol for the Delaware PEAK Randomized Controlled Trial,” Physical Therapy 2 (2023): pzac139.

[548] S. Lee, T. Neogi, K. E. Costello, et al., “Association of Mechanical Temporal Summation of Pain With Muscle co-contraction During Walking in People With Knee Osteoarthritis,” Clin Biomech (Bristol) 110 (2023): 106105.

[549] M. J. Rose, T. Neogi, B. Friscia, et al., “Reliability of Wearable Sensors for Assessing Gait and Chair Stand Function at Home in People with Knee Osteoarthritis,” Arthritis Care Res (Hoboken) 9 (2023): 1939–1948.

[550] R. S. Falck, J. R. Best, L. C. Li, et al., “Can We Improve Cognitive Function Among Adults With Osteoarthritis by Increasing Moderate-to-vigorous Physical Activity and Reducing Sedentary Behaviour? Secondary Analysis of the MONITOR-OA Study,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2018): 447.

[551] L. C. Li, E. C. Sayre, H. Xie, et al., “Efficacy of a Community-Based Technology-Enabled Physical Activity Counseling Program for People with Knee Osteoarthritis: Proof-of-Concept Study,” Journal of Medical Internet Research [Electronic Resource] 4 (2018): e159.

[552] L. R. M. Hausmann, A. Youk, C. K. Kwoh, et al., “Effect of a Positive Psychological Intervention on Pain and Functional Difficulty among Adults with Osteoarthritis: A Randomized Clinical Trial,” JAMA Network Open 5 (2018): e182533.

[553] J. C. Plumb Vilardaga, S. A. Kelleher, A. Diachina, et al., “Linking Physical Activity to Personal Values: Feasibility and Acceptability Randomized Pilot of a Behavioral Intervention for Older Adults With Osteoarthritis Pain,” Pilot Feasibility Stud 1 (2022): 164.

[554] J. M. Charlton, N. M. Krowchuk, J. J. Eng, et al., “Remotely Delivered, Individualized, and Self-directed Gait Modification for Knee Osteoarthritis: A Pilot Trial,” Clin Biomech (Bristol) 106 (2023): 105981.

[555] D. L. Judd, V. A. Cheuy, J. E. Forster, et al., “Incorporating Specific Functional Strength Integration Techniques to Improve Functional Performance for Veterans after Total Hip Arthroplasty: Protocol for a Randomized Clinical Trial,” Physical Therapy 11 (2019): 1453–1460.

[556] K. G. Rabe, H. Matsuse, A. Jackson, et al., “Evaluation of the Combined Application of Neuromuscular Electrical Stimulation and Volitional Contractions on Thigh Muscle Strength, Knee Pain, and Physical Performance in Women at Risk for Knee Osteoarthritis: A Randomized Controlled Trial,” PM R 12 (2018): 1301–1310.

[557] A. M. Wiggins, L. J. Strath, G. E. McPherson, et al., “The Effect of a Low-carbohydrate Diet on Evoked Pain and Quality of Life in Non-Hispanic Black Women With Knee Osteoarthritis: A Pilot Study,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2024): 1043.

[558] M. Mangla, H. Bedair, Y. Chang, et al., “Protocol for a Randomised Trial Evaluating the Comparative Effectiveness of Strategies to Promote Shared Decision Making for Hip and Knee Osteoarthritis (DECIDE-OA study),” BMJ Open 2 (2019): e024906.

[559] C. Lee, J. Park, C. K. Kwoh, et al., “Home-Based, Remotely Supervised Transcranial Direct Current Stimulation Improves the Overall Pain Experience of Older Adults with Knee Osteoarthritis,” Pain Research & Management 2025 (2025): 1783171.

[560] J. Park, H. Tong, Y. Kang, et al., “Comparison of Responders and Nonresponders With Knee Osteoarthritis After Transcranial Direct Current Stimulation,” Pain Manag 9 (2024): 507–518.

[561] G. Martorella, K. Mathis, H. Miao, et al., “Self-administered Transcranial Direct Current Stimulation for Pain in Older Adults With Knee Osteoarthritis: A Randomized Controlled Study,” Brain-Stimulation 4 (2022): 902–909.

[562] T. Blackburn, D. A. Padua, B. Pietrosimone, et al., “Vibration Improves Gait Biomechanics Linked to Posttraumatic Knee Osteoarthritis Following Anterior Cruciate Ligament Injury,” Journal of Orthopaedic Research 5 (2021): 1113–1122.

[563] J. T. Blackburn, B. Pietrosimone, J. T. Spang, et al., “Somatosensory Function Influences Aberrant Gait Biomechanics Following Anterior Cruciate Ligament Reconstruction,” Journal of Orthopaedic Research 3 (2020): 620–628.

[564] T. Blackburn, B. Pietrosimone, J. S. Goodwin, et al., “Co-activation During Gait Following Anterior Cruciate Ligament Reconstruction,” Clin Biomech (Bristol) 67 (2019): 153–159.

[565] S. G. Pill, B. Ahearn, J. M. Tokish, et al., “Amniotic Tissue Injections Are an Effective Alternative to Corticosteroid Injections for Pain Relief and Function in Patients with Severe Knee Osteoarthritis: A Double-Blind, Randomized, Prospective Study,” J Am Acad Orthop Surg Glob Res Rev 1 (2025): e23.00276.

[566] J. R. Garza, R. E. Campbell, F. P. Tjoumakaris, et al., “Clinical Efficacy of Intra-articular Mesenchymal Stromal Cells for the Treatment of Knee Osteoarthritis: A Double-Blinded Prospective Randomized Controlled Clinical Trial,” American Journal of Sports Medicine 3 (2020): 588–598.

[567] D. R. Diduch, D. C. Crawford, A. S. Ranawat, et al., “Implantable Shock Absorber Provides Superior Pain Relief and Functional Improvement Compared with High Tibial Osteotomy in Patients With Mild-to-Moderate Medial Knee Osteoarthritis: A 2-Year Report,” Cartilage 2 (2023): 152–163.

[568] N. O. Sarpong, M. B. Held, M. J. Grosso, et al., “No Benefit to Sensor-guided Balancing Compared with Freehand Balancing in TKA: A Randomized Controlled Trial,” Clinical Orthopaedics and Related Research 8 (2022): 1535–1544.

[569] B. Gheflati, M. Mirzaei, S. Rottoo, et al., “Leveraging Deep Learning for Nonlinear Shape Representation in Anatomically Parameterized Statistical Shape Models,” Int J Comput Assist Radiol Surg 5 (2025): 1035–1046.

[570] X. Qiao, L. Yan, Y. Feng, et al., “Efficacy and Safety of Corticosteroids, Hyaluronic Acid, and PRP and Combination Therapy for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2023): 926.

[571] L. E. Miller, S. Bhattacharyya, W. R. Parrish, et al., “Safety of Intra-Articular Hyaluronic Acid for Knee Osteoarthritis: Systematic Review and Meta-Analysis of Randomized Trials Involving More Than 8,000 Patients,” Cartilage 1_suppl (2021): 351S–363S.

[572] S. I. Kamel, H. G. Rosas, and T. Gorbachova, “Local and Systemic Side Effects of Corticosteroid Injections for Musculoskeletal Indications,” Ajr American Journal of Roentgenology 3 (2024): e2330458.

[573] Z. Paskins, K. Bromley, M. Lewis, et al., “Clinical Effectiveness of One Ultrasound Guided Intra-articular Corticosteroid and Local Anaesthetic Injection in Addition to Advice and Education for Hip Osteoarthritis (HIT trial): Single Blind, Parallel Group, Three Arm, Randomised Controlled Trial,” Bmj 377 (2022): e068446.

[574] P. A. Brookes and S. Stynes, “In Patients with Painful Hip Osteoarthritis, Is It More Beneficial to Offer Them an Ultrasound-Guided or a Fluoroscopic-Guided Intra-Articular Corticosteroid Injection to Relieve Their Symptoms? A Systematic Review and Network Meta-Analysis,” Musculoskeletal Care 4 (2024): e70005.

[575] C. Y. Chang, S. Mittu, M. Da Silva Cardoso, et al., “Outcomes of Imaging-guided Corticosteroid Injections in Hip and Knee Osteoarthritis Patients: A Systematic Review,” Skeletal Radiology 11 (2023): 2297–2308.

[576] X. Wang, P. Wang, A. Faramand, et al., “Efficacy and Safety of Corticosteroid in the Treatment of Hand Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials,” Clinical Rheumatology 6 (2022): 1825–1832.

[577] A. Bensa, A. Sangiorgio, A. Boffa, et al., “Corticosteroid Injections for Knee Osteoarthritis Offer Clinical Benefits Similar to Hyaluronic Acid and Lower Than Platelet-rich Plasma: A Systematic Review and Meta-analysis,” EFORT Open Rev 9 (2024): 883–895.

[578] M. Tschopp, C. W. A. Pfirrmann, S. F. Fucentese, et al., “A Randomized Trial of Intra-articular Injection Therapy for Knee Osteoarthritis,” Investigative Radiology 5 (2023): 355–362.

[579] X. Wang, Q. Sun, M. Wang, et al., “Electrical Dry Needling plus Corticosteroid Injection for Osteoarthritis of the Knee: A Randomized Controlled Trial,” Archives of Physical Medicine and Rehabilitation 5 (2022): 858–866.

[580] C. P. Wang, W. C. Lee, and R. L. Hsieh, “Effects of Repeated Co-Injections of Corticosteroids and Hyaluronic Acid on Knee Osteoarthritis: A Prospective, Double-Blind Randomized Controlled Trial,” American Journal of Medicine 5 (2022): 641–649.

[581] A. Bensa, M. Salerno, A. Boffa, et al., “Corticosteroid Injections for the Treatment of Osteoarthritis Present a Wide Spectrum of Effects Ranging From Detrimental to Disease-modifying: A Systematic Review of Preclinical Evidence by the ESSKA Orthobiologic Initiative,” Knee Surgery, Sports Traumatology, Arthroscopy 11 (2024): 2725–2745.

[582] J. W. Orchard, “Pay Attention to the Evidence: In the Longer Term, Intraarticular Corticosteroid Injections Offer Only Harm for Knee Osteoarthritis,” Osteoarthritis and Cartilage 2 (2023): 142–143.

[583] A. Guermazi, T. Neogi, J. N. Katz, et al., “Intra-articular Corticosteroid Injections for the Treatment of Hip and Knee Osteoarthritis-related Pain: Considerations and Controversies With a Focus on Imaging-Radiology Scientific Expert Panel,” Radiology 3 (2020): 503–512.

[584] R. L. Donovan, T. A. Edwards, A. Judge, et al., “Effects of Recurrent Intra-articular Corticosteroid Injections for Osteoarthritis at 3 Months and Beyond: A Systematic Review and Meta-analysis in Comparison to Other Injectables,” Osteoarthritis and Cartilage 12 (2022): 1658–1669.

[585] S. Ayub, J. Kaur, M. Hui, et al., “Efficacy and Safety of Multiple Intra-articular Corticosteroid Injections for Osteoarthritis-a Systematic Review and Meta-analysis of Randomized Controlled Trials and Observational Studies,” Rheumatology (Oxford) 4 (2021): 1629–1639.

[586] Y. Cao, R. Cai, S. Han, et al., “Quantitative Analysis of the Efficacy and Associated Factors of Intra-articular Hyaluronic Acid With Respect to Osteoarthritis Symptoms: A Systematic Review of Randomized Trials and Model-based Meta-analysis,” Osteoarthritis and Cartilage 6 (2025): 666–679.

[587] X. Chevalier and B. Sheehan, “Predictors of Clinical Benefit With Intra-articular Hyaluronic Acid in Patients With Knee Osteoarthritis—A Narrative Review,” Curr Rheumatol Rev 4 (2024): 379–387.

[588] S. L. Sherman, A. S. Gudeman, J. D. Kelly, et al., “Mechanisms of Action of Intra-articular Hyaluronic Acid Injections for Knee Osteoarthritis: A Targeted Review of the Literature,” American Journal of Sports Medicine 11 (2025): 2771–2782.

[589] D. C. Fasanello, J. Su, S. Deng, et al., “Hyaluronic Acid Synthesis, Degradation, and Crosslinking in Equine Osteoarthritis: TNF-alpha-TSG-6-mediated HC-HA Formation,” Arthritis Research & Therapy 1 (2021): 218.

[590] M. Fonsi, A. I. El Amrani, F. Gervais, et al., “Intra-Articular Hyaluronic Acid and Chondroitin Sulfate: Pharmacokinetic Investigation in Osteoarthritic Rat Models,” Current Therapeutic Research, Clinical and Experimental 92 (2020): 100573.

[591] F. Familiari, A. Ammendolia, M. C. Rupp, et al., “Efficacy of Intra-articular Injections of Hyaluronic Acid in Patients With Glenohumeral Joint Osteoarthritis: A Systematic Review and Meta-analysis,” Journal of Orthopaedic Research 11 (2023): 2345–2358.

[592] W. S. Hill, M. H. Dohnalek, Y. Ha, et al., “A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Krill Oil, Astaxanthin, and Oral Hyaluronic Acid Complex on Joint Health in People With Mild Osteoarthritis,” Nutrients 17 (2023): 3769.

[593] A. Ranawat, K. Guo, M. Phillips, et al., “Health Economic Assessments of Hyaluronic Acid Treatments for Knee Osteoarthritis: A Systematic Review,” Advances in Therapy 1 (2024): 65–81.

[594] E. Ferkel, A. Manjoo, D. Martins, et al., “Intra-articular Hyaluronic Acid Treatments for Knee Osteoarthritis: A Systematic Review of Product Properties,” Cartilage 4 (2023): 424–432.

[595] D. Webner, Y. Huang, and C. D. Hummer, “Intraarticular Hyaluronic Acid Preparations for Knee Osteoarthritis: Are Some Better than Others?,” Cartilage 1_suppl (2021): 1619S–1636S.

[596] F. Migliorini, M. Pilone, M. G. Mazzoleni, et al., “Intra-articular Hyaluronic Acid Injections for Hip Osteoarthritis: A Level I Systematic Review,” Eur J Orthop Surg Traumatol 1 (2025): 180.

[597] A. Paichitrojjana and A. Paichitrojjana, “Platelet Rich Plasma and Its Use in Hair Regrowth: A Review,” Drug Des Devel Ther 16 (2022): 635–645.

[598] P. Everts, K. Onishi, P. Jayaram, et al., “Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020,” International Journal of Molecular Sciences 20 (2020): 7794.

[599] D. Szwedowski, J. Szczepanek, L. Paczesny, et al., “The Effect of Platelet-Rich Plasma on the Intra-Articular Microenvironment in Knee Osteoarthritis,” International Journal of Molecular Sciences 11 (2021): 5492.

[600] M. Simental-Mendia, D. Ortega-Mata, and C. A. Acosta-Olivo, “Platelet-Rich Plasma for Knee Osteoarthritis: What Does the Evidence Say?,” Drugs & Aging 7 (2023): 585–603.

[601] Z. Zhao, J. X. Ma, and X. L. Ma, “Different Intra-articular Injections as Therapy for Hip Osteoarthritis: A Systematic Review and Network Meta-analysis,” Arthroscopy 5 (2020): 1452-1464 e1452.

[602] S. A. Raeissadat, P. Ghazi Hosseini, M. H. Bahrami, et al., “The Comparison Effects of Intra-articular Injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and Ozone in Knee Osteoarthritis; a One Year Randomized Clinical Trial,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2021): 134.

[603] H. Bansal, J. Leon, J. L. Pont, et al., “Platelet-rich Plasma (PRP) in Osteoarthritis (OA) Knee: Correct Dose Critical for Long Term Clinical Efficacy,” Scientific Reports 1 (2021): 3971.

[604] M. McLarnon and N. Heron, “Intra-articular Platelet-rich Plasma Injections versus Intra-articular Corticosteroid Injections for Symptomatic Management of Knee Osteoarthritis: Systematic Review and Meta-analysis,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2021): 550.

[605] J. F. Oeding, N. H. Varady, F. W. Fearington, et al., “Platelet-Rich Plasma versus Alternative Injections for Osteoarthritis of the Knee: A Systematic Review and Statistical Fragility Index-Based Meta-analysis of Randomized Controlled Trials,” American Journal of Sports Medicine 12 (2024): 3147–3160.

[606] S. Laohajaroensombat, S. Prusmetikul, S. Rattanasiri, et al., “Platelet-rich Plasma Injection for the Treatment of Ankle Osteoarthritis: A Systematic Review and Meta-analysis,” Journal of Orthopaedic Surgery and Research 1 (2023): 373.

[607] J. W. Belk, J. J. Lim, C. Keeter, et al., “Patients with Knee Osteoarthritis Who Receive Platelet-Rich Plasma or Bone Marrow Aspirate Concentrate Injections Have Better Outcomes than Patients Who Receive Hyaluronic Acid: Systematic Review and Meta-analysis,” Arthroscopy 7 (2023): 1714–1734.

[608] L. A. V. Costa, M. Lenza, J. J. Irrgang, et al., “How Does Platelet-Rich Plasma Compare Clinically to Other Therapies in the Treatment of Knee Osteoarthritis? A Systematic Review and Meta-analysis,” American Journal of Sports Medicine 4 (2023): 1074–1086.

[609] J. W. Belk, M. J. Kraeutler, D. A. Houck, et al., “Platelet-Rich Plasma versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials,” American Journal of Sports Medicine 1 (2021): 249–260.

[610] A. Boffa, L. De Marziani, L. Andriolo, et al., “Influence of Platelet Concentration on the Clinical Outcome of Platelet-Rich Plasma Injections in Knee Osteoarthritis,” American Journal of Sports Medicine 13 (2024): 3223–3231.

[611] M. Mata, R. Salvador-Clavell, J. Rodenas-Rochina, et al., “Mesenchymal Stem Cells Cultured in a 3D Microgel Environment Containing Platelet-Rich Plasma Significantly Modify Their Chondrogenesis-Related miRNA Expression,” International Journal of Molecular Sciences 2 (2024): 937.

[612] F. Liu, H. Xu, and H. Huang, “A Novel Kartogenin-platelet-rich Plasma Gel Enhances Chondrogenesis of Bone Marrow Mesenchymal Stem Cells in Vitro and Promotes Wounded Meniscus Healing in Vivo,” Stem Cell Res Ther 1 (2019): 201.

[613] J. Shen, Q. Gao, Y. Zhang, et al., “Autologous Platelet-Rich Plasma Promotes Proliferation and Chondrogenic Differentiation of Adipose-Derived Stem Cells,” Molecular Medicine Reports 2 (2015): 1298–1303.

[614] M. G. Scioli, A. Bielli, P. Gentile, et al., “Combined Treatment With Platelet-rich Plasma and Insulin Favours Chondrogenic and Osteogenic Differentiation of human Adipose-derived Stem Cells in Three-dimensional Collagen Scaffolds,” J Tissue Eng Regen Med 8 (2017): 2398–2410.

[615] M. Berney, P. McCarroll, L. Glynn, et al., “Platelet-rich Plasma Injections for Hip Osteoarthritis: A Review of the Evidence,” Irish Journal of Medical Science 3 (2021): 1021–1025.

[616] K. L. Bennell, K. L. Paterson, B. R. Metcalf, et al., “Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients with Knee Osteoarthritis: The RESTORE Randomized Clinical Trial,” Jama 20 (2021): 2021–2030.

[617] L. D. A. Paget, G. Reurink, R. J. de Vos, et al., “Platelet-Rich Plasma Injections for the Treatment of Ankle Osteoarthritis,” American Journal of Sports Medicine 10 (2023): 2625–2634.

[618] L. D. A. Paget, G. Reurink, R. J. de Vos, et al., “Effect of Platelet-Rich Plasma Injections vs Placebo on Ankle Symptoms and Function in Patients with Ankle Osteoarthritis: A Randomized Clinical Trial,” Jama 16 (2021): 1595–1605.

[619] E. Kon, L. de Girolamo, L. Laver, et al., “Platelet-rich Plasma Injections for the Management of Knee Osteoarthritis: The ESSKA-ICRS Consensus. Recommendations Using the RAND/UCLA Appropriateness Method for Different Clinical Scenarios,” Knee Surgery, Sports Traumatology, Arthroscopy 11 (2024): 2938–2949.

[620] S. A. Raeissadat, M. Rahimi, S. M. Rayegani, et al., “Cost-utility Analysis and Net Monetary Benefit of Platelet Rich Plasma (PRP), Intra-articular Injections in Compared to Plasma Rich in Growth Factors (PRGF), Hyaluronic Acid (HA) and Ozone in Knee Osteoarthritis in Iran,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2023): 22.

[621] X. Lin, F. Zhi, Q. Lan, et al., “Comparing the Efficacy of Different Intra-articular Injections for Knee Osteoarthritis: A Network Analysis,” Medicine (Baltimore) 31 (2022): e29655.

[622] J. Dubin, P. Leucht, M. Murray, et al., “American Academy of Orthopaedic Surgeons Technology Overview Summary: Platelet-Rich Plasma (PRP) for Knee Osteoarthritis,” Journal of the American Academy of Orthopaedic Surgeons 7 (2024): 296–301.

[623] M. Derwich, M. Mitus-Kenig, and E. Pawlowska, “Mechanisms of Action and Efficacy of Hyaluronic Acid, Corticosteroids and Platelet-Rich Plasma in the Treatment of Temporomandibular Joint Osteoarthritis-A Systematic Review,” International Journal of Molecular Sciences 14 (2021): 7405.

[624] G. B. Kim, M. S. Seo, W. T. Park, et al., “Bone Marrow Aspirate Concentrate: Its Uses in Osteoarthritis,” International Journal of Molecular Sciences 9 (2020): 3224.

[625] J. S. Lee, S. M. Gillinov, B. S. Siddiq, et al., “Surgical Applications for Bone Marrow Aspirate Concentrate,” Arthroscopy 9 (2024): 2350–2352.

[626] J. Chahla, C. S. Dean, G. Moatshe, et al., “Concentrated Bone Marrow Aspirate for the Treatment of Chondral Injuries and Osteoarthritis of the Knee: A Systematic Review of Outcomes,” Orthop J Sports Med 1 (2016): 2325967115625481.

[627] W. N. Zeng, Y. Zhang, D. Wang, et al., “Intra-articular Injection of Kartogenin-Enhanced Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis in a Rat Model,” American Journal of Sports Medicine 10 (2021): 2795–2809.

[628] E. C. Doyle, N. M. Wragg, and S. L. Wilson, “Intraarticular Injection of Bone Marrow-derived Mesenchymal Stem Cells Enhances Regeneration in Knee Osteoarthritis,” Knee Surgery, Sports Traumatology, Arthroscopy 12 (2020): 3827–3842.

[629] C. T. Vangsness Jr., J. Farr 2nd, J. Boyd, et al., “Adult human Mesenchymal Stem Cells Delivered via Intra-articular Injection to the Knee Following Partial Medial Meniscectomy: A Randomized, Double-blind, Controlled Study,” Journal of Bone and Joint Surgery American Volume 2 (2014): 90–98.

[630] C. G. Ziegler, R. Van Sloun, S. Gonzalez, et al., “Characterization of Growth Factors, Cytokines, and Chemokines in Bone Marrow Concentrate and Platelet-Rich Plasma: A Prospective Analysis,” American Journal of Sports Medicine 9 (2019): 2174–2187.

[631] C. J. Centeno, H. Al-Sayegh, J. Bashir, et al., “A Dose Response Analysis of a Specific Bone Marrow Concentrate Treatment Protocol for Knee Osteoarthritis,” BMC Musculoskeletal Disorders [Electronic Resource] 16 (2015): 258.

[632] O. Dulic, P. Rasovic, I. Lalic, et al., “Bone Marrow Aspirate Concentrate versus Platelet Rich Plasma or Hyaluronic Acid for the Treatment of Knee Osteoarthritis,” Medicina (Kaunas) 11 (2021): 1193.

[633] S. Chandrashekar, M. Jeyaraman, P. Mounissamy, et al., “Safety and Efficacy of Bone-Marrow Aspirate Concentrate in Hip Osteoarthritis: A Systematic Review of Current Clinical Evidence,” Indian J Orthop 7 (2024): 835–844.

[634] M. Jeyaraman, N. Jeyaraman, S. Ramasubramanian, et al., “Bone Marrow Aspirate Concentrate for Treatment of Primary Knee Osteoarthritis: A Prospective, Single-Center, Non-randomized Study With 2-Year Follow-Up,” Indian J Orthop 7 (2024): 894–904.

[635] H. M. Fayed, M. A. Khairy, D. Eldahshan, et al., “Bone Marrow Aspirate Concentrate—A Novel Approach to Alter the Course of Temporomandibular Joint Osteoarthritis (a clinical study),” J Stomatol Oral Maxillofac Surg 1 (2024): 101644.

[636] A. Pintore, D. Notarfrancesco, A. Zara, et al., “Intra-articular Injection of Bone Marrow Aspirate Concentrate (BMAC) or Adipose-derived Stem Cells (ADSCs) for Knee Osteoarthritis: A Prospective Comparative Clinical Trial,” Journal of Orthopaedic Surgery and Research 1 (2023): 350.

[637] A. B. Yanke, A. A. Yazdi, A. C. Weissman, et al., “A Prospective, Randomized, Double-Blind Clinical Trial to Investigate the Efficacy of Autologous Bone Marrow Aspirate Concentrate during Arthroscopic Meniscectomy in Patients with Early Knee Osteoarthritis,” American Journal of Sports Medicine 12 (2024): 2963–2971.

[638] S. A. Shapiro, S. E. Kazmerchak, M. G. Heckman, et al., “A Prospective, Single-Blind, Placebo-Controlled Trial of Bone Marrow Aspirate Concentrate for Knee Osteoarthritis,” American Journal of Sports Medicine 1 (2017): 82–90.

[639] F. Migliorini, M. Pilone, J. Ascani, et al., “Management of Knee Osteoarthritis Using Bone Marrow Aspirate Concentrate: A Systematic Review,” British Medical Bulletin 1 (2025): ldae016.

[640] J. H. Han, M. Jung, K. Chung, et al., “Bone Marrow Aspirate Concentrate Injections for the Treatment of Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials,” Orthop J Sports Med 12 (2024): 23259671241296555.

[641] L. E. Keeling, J. W. Belk, M. J. Kraeutler, et al., “Bone Marrow Aspirate Concentrate for the Treatment of Knee Osteoarthritis: A Systematic Review,” American Journal of Sports Medicine 8 (2022): 2315–2323.

[642] D. Park, H. S. Koh, Y. H. Choi, et al., “Bone Marrow Aspirate Concentrate (BMAC) for Knee Osteoarthritis: A Narrative Review of Clinical Efficacy and Future Directions,” Medicina (Kaunas) 5 (2025): 853.

[643] C. Sconza, B. Di Matteo, P. Queirazza, et al., “Ozone Therapy versus Hyaluronic Acid Injections for Pain Relief in Patients With Knee Osteoarthritis: Preliminary Findings on Molecular and Clinical Outcomes From a Randomized Controlled Trial,” International Journal of Molecular Sciences 10 (2023): 8788.

[644] F. Migliorini, R. Giorgino, M. G. Mazzoleni, et al., “Intra-articular Injections of Ozone versus Hyaluronic Acid for Knee Osteoarthritis: A Level I Meta-analysis,” Eur J Orthop Surg Traumatol 1 (2024): 20.

[645] C. Yang and Q. Chen, “Effects of Ozone Combined With Articular Injection of Sodium Hyaluronate on Patients With Knee Osteoarthritis and Their Inflammatory Factors and Hemorheological Indices,” African Health Sciences 2 (2023): 360–366.

[646] S. G. Aslan, A. de Sire, S. U. Koylu, et al., “The Efficacy of Ultrasonography-guided Oxygen-ozone Therapy versus Corticosteroids in Patients With Knee Osteoarthritis: A Multicenter Randomized Controlled Trial,” J Back Musculoskelet Rehabil 6 (2024): 1455–1466.

[647] S. Fakhari, A. Pishghahi, H. Pourfathi, et al., “A Comparison between Low-Level Laser Therapy and Intra-articular Ozone Injection in Knee Osteoarthritis Treatment: A Randomized Clinical Trial,” J Lasers Med Sci 12 (2021): e44.

[648] E. Ata, S. Ozguc, M. H. Temel, et al., “The Impact of Ex Vivo Ozone Injection Into the Synovial Fluid in Patients With Knee Osteoarthritis: A Controlled Clinical Trial,” Arch Rheumatol 3 (2024): 459–466.

[649] Z. Arjmanddoust, A. Nazari, and A. Moezy, “Efficacy of Two Doses of Intra-articular Ozone Therapy for Pain and Functional Mobility in Knee Osteoarthritis: A Double-blind Randomized Trial,” Adv Rheumatol 1 (2025): 11.

[650] M. Nazarieh, S. Ghannadi, F. Halabchi, et al., “The Effect of Intra-articular Ozone Injection Combined With Home-based Exercise on Pain and Function in Daily Living Activities of Patients With Mild to Moderate Knee Osteoarthritis, a Randomized Double-blinded Controlled Clinical Trial,” J Bodyw Mov Ther 38 (2024): 541–548.

[651] J. Wu, Z. Zhou, Y. Huang, et al., “Radiofrequency Ablation: Mechanisms and Clinical Applications,” MedComm 10 (2024): e746.

[652] A. Conger, J. Gililland, L. Anderson, et al., “Genicular Nerve Radiofrequency Ablation for the Treatment of Painful Knee Osteoarthritis: Current Evidence and Future Directions,” Pain Med Suppl 1 (2021): S20–S23.

[653] Y. Liu, X. Zhao, J. Zhou, et al., “Radiofrequency Ablation Therapy for Knee Osteoarthritis: A Systematic Review and Meta-analysis,” Cirugia Y Cirujanos 4 (2024): 456–468.

[654] G. Li, Y. Zhang, L. Tian, et al., “Radiofrequency Ablation Reduces Pain for Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials,” Int J Surg 91 (2021): 105951.

[655] R. Correia, L. Oliveira, I. Andrade, et al., “Ultrasound-Guided Radiofrequency Ablation for Chronic Hip Pain due to Osteoarthritis,” Cureus 2 (2024): e53743.

[656] J. Wen, B. Syed, S. Dwyer, et al., “Radiofrequency Ablation of the First Carpometacarpal Joint for Osteoarthritis: A Technical Report,” Pain Medicine 10 (2025): 689–693.

[657] Y. W. Chang, I. S. Tzeng, K. C. Lee, et al., “Functional Outcomes and Physical Performance of Knee Osteoarthritis Patients after Ultrasound-Guided Genicular Nerve Radiofrequency Ablation,” Pain Medicine 2 (2022): 352–361.

[658] N. Kanjanapanang, R. Madrid, P. Lin, et al., “Effectiveness of Genicular Nerve Radiofrequency Ablation in Osteoarthritis and Post-surgical Knee Pain: Systematic Review,” Pain Medicine 2 (2025): 189–208.

[659] J. Chen, Q. Zhou, W. Yu, et al., “A Critical Overview of Systematic Reviews of Radiofrequency Ablation for Knee Osteoarthritis,” Disability and Rehabilitation 20 (2025): 5161–5170.

[660] Y. Huang, Q. Deng, L. Yang, et al., “Efficacy and Safety of Ultrasound-Guided Radiofrequency Treatment for Chronic Pain in Patients With Knee Osteoarthritis: A Systematic Review and Meta-Analysis,” Pain Research & Management 2020 (2020): 2537075.

[661] Y. Ma, Y. S. Chen, B. Liu, et al., “Ultrasound-Guided Radiofrequency Ablation for Chronic Osteoarthritis Knee Pain in the Elderly: A Randomized Controlled Trial,” Pain Physician 3 (2024): 121–128.

[662] H. Zhang, B. Wang, J. He, et al., “Efficacy and Safety of Radiofrequency Ablation for Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials,” Journal of International Medical Research 4 (2021): 3000605211006647.

[663] A. F. Chen, K. Mullen, F. Casambre, et al., “Thermal Nerve Radiofrequency Ablation for the Nonsurgical Treatment of Knee Osteoarthritis: A Systematic Literature Review,” Journal of the American Academy of Orthopaedic Surgeons 9 (2021): 387–396.

[664] A. E. Fogarty, T. Burnham, K. Kuo, et al., “The Effectiveness of Fluoroscopically Guided Genicular Nerve Radiofrequency Ablation for the Treatment of Chronic Knee Pain due to Osteoarthritis: A Systematic Review,” American Journal of Physical Medicine & Rehabilitation 5 (2022): 482–492.

[665] S. Park, S. Park, J. N. Jang, et al., “Radiofrequency Ablation versus Intra-articular Mesenchymal Stem Cell Injection for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis,” Regional Anesthesia and Pain Medicine 9 (2025): 747–758.

[666] S. Anwar, S. Vardhan, A. Aggarwal, et al., “Safety and Efficacy of Platelet-Rich Plasma versus Genicular Nerve Radiofrequency Ablation in Knee Osteoarthritis: An Open-Label, Prospective, Randomized, Clinical Trial,” Pain Physician 3 (2025): 207–215.

[667] A. Elawamy, E. Z. Kamel, S. A. Mahran, et al., “Efficacy of Genicular Nerve Radiofrequency Ablation versus Intra-Articular Platelet Rich Plasma in Chronic Knee Osteoarthritis: A Single-Blind Randomized Clinical Trial,” Pain Physician 2 (2021): 127–134.

[668] A. Gupta, D. P. Huettner, and M. Dukewich, “Comparative Effectiveness Review of Cooled versus Pulsed Radiofrequency Ablation for the Treatment of Knee Osteoarthritis: A Systematic Review,” Pain Physician 3 (2017): 155–171.

[669] M. H. Karm, H. J. Kwon, C. S. Kim, et al., “Cooled Radiofrequency Ablation of Genicular Nerves for Knee Osteoarthritis,” Korean J Pain 1 (2024): 13–25.

[670] C. M. Tidwell and P. J. DeMarco, “Temperature-Mediated Neural Interventions in Knee Osteoarthritis: A Review of Cryoneurolysis and Cooled Radiofrequency Ablation With Ultrasound Guidance,” Current Rheumatology Reports 3 (2024): 89–95.

[671] K. Hiromura, H. Kitajima, C. Hatakenaka, et al., “Short-Term Effects of Cooled Radiofrequency Ablation on Walking Ability in Japanese Patients With Knee Osteoarthritis,” Journal of Clinical Medicine 23 (2024): 7049.

[672] A. F. Chen, F. Khalouf, K. Zora, et al., “Cooled Radiofrequency Ablation Compared With a Single Injection of Hyaluronic Acid for Chronic Knee Pain: A Multicenter, Randomized Clinical Trial Demonstrating Greater Efficacy and Equivalent Safety for Cooled Radiofrequency Ablation,” Journal of Bone and Joint Surgery American Volume 17 (2020): 1501–1510.

[673] B. Soetjahjo, D. Adriansyah, M. B. Yudistira, et al., “The Analgesic Effectiveness of Genicular Nerve-targeted Cooled and Pulsed Radiofrequency Ablation for Osteoarthritis Knee Pain: A Systematic Review and Meta-analysis,” Pain Physician 7 (2024): 357–373.

[674] A. Papa, M. T. Di Dato, G. Lo Bianco, et al., “Intraarticular STP Radiofrequency for Painful Osteoarthritis in the Knee: A Retrospective Single Center Analysis,” J Pain Res 14 (2021): 2441–2447.

[675] H. Uematsu, S. Osako, S. Hakata, et al., “A Double-Blind, Placebo-Controlled Study of Ultrasound-Guided Pulsed Radiofrequency Treatment of the Saphenous Nerve for Refractory Osteoarthritis-Associated Knee Pain,” Pain Physician 6 (2021): E761–E769.

[676] L. Wu, Y. Li, H. Si, et al., “Radiofrequency Ablation in Cooled Monopolar or Conventional Bipolar Modality Yields More Beneficial Short-Term Clinical Outcomes versus Other Treatments for Knee Osteoarthritis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials,” Arthroscopy 7 (2022): 2287–2302.

[677] T. Hong, G. Li, Z. Han, et al., “Comparing the Safety and Effectiveness of Radiofrequency Thermocoagulation on Genicular Nerve, Intraarticular Pulsed Radiofrequency With Steroid Injection in the Pain Management of Knee Osteoarthritis,” Pain Physician 4S (2020): S295–S304.

[678] M. M. Santana-Pineda, L. E. Vanlinthout, S. Santana-Ramirez, et al., “A Randomized Controlled Trial to Compare Analgesia and Functional Improvement after Continuous Neuroablative and Pulsed Neuromodulative Radiofrequency Treatment of the Genicular Nerves in Patients With Knee Osteoarthritis up to One Year after the Intervention,” Pain Medicine 3 (2021): 637–652.

[679] S. D. Martin, M. C. Dean, S. M. Gillinov, et al., “Hip Arthroscopy versus Physical Therapy for the Treatment of Symptomatic Acetabular Labral Tears in Patients Older than 40 Years: 24-Month Results from a Randomized Controlled Trial,” American Journal of Sports Medicine 10 (2024): 2574–2585.

[680] L. Sivasundaram, M. W. Rice, N. S. Horner, et al., “Hip Arthroscopy for the Treatment of Femoroacetabular Impingement Syndrome in Hips with Mild Osteoarthritis (Tonnis Grade 1): A Matched Comparative Cohort Analysis at Minimum 5-Year Follow-up,” American Journal of Sports Medicine 10 (2022): 2598–2605.

[681] A. Shanmugaraj, M. V. Kumar, O. Al Naji, et al., “Hip Arthroscopy Improves Outcomes with Moderate Conversion to Total Hip Arthroplasty Rates in Patients Aged 50 Years or Older: A Systematic Review,” Arthroscopy 6 (2023): 1539-1551 e1531.

[682] C. Kyin, D. R. Maldonado, C. C. Go, et al., “Mid- to Long-Term Outcomes of Hip Arthroscopy: A Systematic Review,” Arthroscopy 3 (2021): 1011–1025.

[683] M. Husen, D. P. Leland, H. P. Melugin, et al., “Progression of Osteoarthritis at Long-term Follow-up in Patients Treated for Symptomatic Femoroacetabular Impingement with Hip Arthroscopy Compared with Nonsurgically Treated Patients,” American Journal of Sports Medicine 11 (2023): 2986–2995.

[684] P. N. Ramkumar, R. J. Olsen, H. J. F. Shaikh, et al., “Modern Hip Arthroscopy for FAIS May Delay the Natural History of Osteoarthritis in 25% of Patients: A 12-Year Follow-up Analysis,” American Journal of Sports Medicine 5 (2024): 1137–1143.

[685] S. Nikou, C. Sandlund, I. Lindman, et al., “Ten-year Outcomes of Hip Arthroscopy for Femoroacetabular Impingement With Osteoarthritis: Sustained Functional Benefits but High Conversion to Total Hip Arthroplasty,” Knee Surgery, Sports Traumatology, Arthroscopy 7 (2025): 2655–2663.

[686] O. Andronic, L. S. Claydon-Mueller, R. Cubberley, et al., “Inconclusive and Contradictory Evidence for Outcomes after Hip Arthroscopy in Patients with Femoroacetabular Impingement and Osteoarthritis of Tonnis Grade 2 or Greater: A Systematic Review,” Arthroscopy 7 (2022): 2307-2318 e2301.

[687] C. Khatri, E. Dickenson, I. Ahmed, et al., “ARthroscopy in Knee OsteoArthritis (ARK-OA): A Multicentre Study Assessing Compliance to National Guidelines,” Eur J Orthop Surg Traumatol 7 (2021): 1443–1449.

[688] T. B. Birmingham, C. A. Primeau, S. Z. Shariff, et al., “Incidence of Total Knee Arthroplasty after Arthroscopic Surgery for Knee Osteoarthritis: A Secondary Analysis of a Randomized Clinical Trial,” JAMA Network Open 4 (2024): e246578.

[689] A. Gu, S. C. Fassihi, L. E. Wessel, et al., “Comparison of Revision Risk Based on Timing of Knee Arthroscopy Prior to Total Knee Arthroplasty,” Journal of Bone and Joint Surgery American Volume 8 (2021): 660–667.

[690] A. Giorgini, F. Selleri, F. Zambianchi, et al., “Autologous Micro-fragmented Adipose Tissue Associated With Arthroscopy in Moderate-severe Knee Osteoarthritis: Outcome at Two Year Follow-up,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2022): 963.

[691] M. Vasso, K. Corona, L. Capasso, et al., “Intraarticular Injection of Microfragmented Adipose Tissue plus Arthroscopy in Isolated Primary Patellofemoral Osteoarthritis Is Clinically Effective and Not Affected by Age, BMI, or Stage of Osteoarthritis,” J Orthop Traumatol 1 (2022): 7.

[692] X. Hu, Z. Zhang, W. Zhang, et al., “Efficacy and Safety of Micro-fragmented Adipose Tissue Combined With Knee Arthroscopy in the Treatment of Knee Osteoarthritis: A Systematic Review,” Journal of Orthopaedic Surgery and Research 1 (2025): 646.

[693] S. Fujimura, S. Omokawa, H. Hasegawa, et al., “Arthroscopy-Assisted Surgery for Trapeziometacarpal Osteoarthritis,” J Hand Surg Asian Pac 1 (2024): 12–16.

[694] S. Moosmayer, O. M. Ekeberg, H. B. Hallgren, et al., “Ultrasound Guided Lavage With Corticosteroid Injection versus Sham Lavage With and Without Corticosteroid Injection for Calcific Tendinopathy of Shoulder: Randomised Double Blinded Multi-arm Study,” Bmj 29 (2023): e076447.

[695] B. D. Springer, C. A. Higuera-Rueda, B. C. de Beaubien, et al., “Safety Profile of Seven-Day Intra-articular Antibiotic Irrigation for the Treatment of Chronic Periprosthetic Joint Infection: A Prospective Randomized Phase II Comparative Study,” Journal of Arthroplasty 9S1 (2024): S229-S235 e221.

[696] S. Li, X. Jiang, J. Wang, et al., “Clinical Efficacy of 2-Needle Joint Lavage for Osteoarthritis-Related Knee Pain and Predictors of Response Based on Knee MRI Osteoarthritis Knee Score: A Medical Records Review Study,” J Clin Rheumatol 8 (2023): 396–401.

[697] M. Dinc and O. Cevdet Soydemir, “Exploring the Efficacy of Joint Lavage in Knee Osteoarthritis: A Focus on Cytokines, Degrading Enzymes, and Oxidative Stress,” Cartilage 16 (2024): 19476035241304526.

[698] Y. Zhang, B. Zhang, W. Li, et al., “Effects of Joint Irrigation Combined With Ozone Injection on Bone Metabolism, Inflammatory Factors, and Joint Function in Knee Osteoarthritis,” American journal of translational research 1 (2023): 213–222.

[699] F. N. Fleckenstein, T. Maleitzke, T. A. Auer, et al., “Genicular Artery Embolization for the Treatment of Symptomatic Knee Osteoarthritis,” Radiology 1 (2025): e243648.

[700] R. Tyagi, S. S. Ahmed, Y. Koethe, et al., “Genicular Artery Embolization for Primary Knee Osteoarthritis,” Semin Intervent Radiol 2 (2022): 125–129.

[701] T. Callese, L. R. Cusumano, H. Sparks, et al., “Early Intervention in Knee Osteoarthritis With Genicular Artery Embolization Is Associated With Improved Clinical Outcomes,” European Radiology 12 (2025): 7617–7626.

[702] S. Landers, R. Hely, A. Hely, et al., “Genicular Artery Embolization for Early-stage Knee Osteoarthritis: Results From a Triple-blind Single-centre Randomized Controlled Trial,” Bone Jt Open 3 (2023): 158–167.

[703] L. R. Cusumano, H. D. Sparks, K. E. Masterson, et al., “Genicular Artery Embolization for Treatment of Symptomatic Knee Osteoarthritis: 2-Year Outcomes From a Prospective IDE Trial,” Journal of Vascular and Interventional Radiology 12 (2024): 1768–1775.

[704] C. Sun, Y. Chen, Z. Gao, et al., “Genicular Artery Embolization for the Treatment of Knee Pain Secondary to Mild to Severe Knee Osteoarthritis: One Year Clinical Outcomes,” European Journal of Radiology 175 (2024): 111443.

[705] D. H. Kwak, H. L. Hofmann, M. Patel, et al., “Genicular Artery Embolization, Radiofrequency Ablation, and Corticosteroid Therapy for Knee Osteoarthritis: A Cost-Effectiveness Analysis Using Randomized Clinical Trial Data,” Ajr American Journal of Roentgenology 6 (2024): e2431710.

[706] R. Abussa and A. Jeremic, “Bridging the Gap Between Injections and Surgery: Meta-Analysis of Genicular Artery Embolization in Knee Osteoarthritis,” Academic Radiology 11 (2025): 6796–6811.

[707] T. B. Birmingham, C. A. Primeau, R. F. Moyer, et al., “High Tibial Osteotomy for Medial Compartment Knee Osteoarthritis: A Randomized Trial with Parallel Preference Arm,” Annals of Internal Medicine 9 (2025): 1238–1248.

[708] H. F. Atkinson, T. B. Birmingham, C. A. Primeau, et al., “Association Between Changes in Knee Load and Effusion-synovitis: Evidence of Mechano-inflammation in Knee Osteoarthritis Using High Tibial Osteotomy as a Model,” Osteoarthritis and Cartilage 2 (2021): 222–229.

[709] K. Kumagai, H. Fujimaki, S. Yamada, et al., “Changes of Synovial Fluid Biomarker Levels After Opening Wedge High Tibial Osteotomy in Patients With Knee Osteoarthritis,” Osteoarthritis and Cartilage 7 (2021): 1020–1028.

[710] S. Yoshida, K. Nishitani, H. Yoshitomi, et al., “Knee Alignment Correction by High Tibial Osteotomy Reduces Symptoms and Synovial Inflammation in Knee Osteoarthritis Accompanied by Macrophage Phenotypic Change from M1 to M2,” Arthritis & Rheumatology 6 (2023): 950–960.

[711] K. Goshima, T. Sawaguchi, T. Horii, et al., “Patellofemoral Osteoarthritis Progression after Open-Wedge High Tibial Osteotomy Does Not Affect the Clinical Outcomes or Survivorship at Minimum 7 Years' Follow-Up,” Arthroscopy 1 (2024): 93–102.

[712] K. Kataoka, S. Watanabe, K. Nagai, et al., “Patellofemoral Osteoarthritis Progresses after Medial Open-Wedge High Tibial Osteotomy: A Systematic Review,” Arthroscopy 10 (2021): 3177–3186.

[713] B. S. Bae, J. W. Jung, G. O. Jo, et al., “Treatment of Osteoarthritic Knee With High Tibial Osteotomy and Allogeneic human Umbilical Cord Blood-derived Mesenchymal Stem Cells Combined With Hyaluronate Hydrogel Composite,” Stem Cell Res Ther 1 (2025): 211.

[714] Z. X. Wu, W. X. Ren, and Z. Q. Wang, “Proximal Fibular Osteotomy versus High Tibial Osteotomy for Treating Knee Osteoarthritis: A Systematic Review and Meta-analysis,” Journal of Orthopaedic Surgery and Research 1 (2022): 470.

[715] Q. Sun, K. Zhang, D. Yang, et al., “Proximal Fibular Osteotomy Definitively Ameliorates Medial Compartment Knee Osteoarthritis: A Finite Element Analysis,” J Orthop 69 (2025): 47–52.

[716] J. E. Morales Avalos, R. Morales-Avalos, K. V. Martinez-Guajardo, et al., “How Effective Is Proximal Fibular Osteotomy in Redistributing Joint Pressures? Insights From an HTO Comparative in-silico Study,” Journal of Orthopaedic Surgery and Research 1 (2024): 333.

[717] L. Prakash and S. A. Dhar, “Proximal Fibular Osteotomy: Biomechanics, Indications, Technique, and Results,” Orthopedics 6 (2020): e627–e631.

[718] S. Kumar, S. Srivastava, S. Kumar, et al., “Proximal Fibular Osteotomy for Medial Joint Osteoarthritis of the Knee: A Prospective Cohort Study,” Cureus 11 (2021): e19180.

[719] V. Bajaj, T. Khare, A. K. Singh, et al., “Proximal Fibular Osteotomy in the Management of Medial Compartment Osteoarthritis of the Knee: A Prospective Study,” Cureus 8 (2025): e89751.

[720] Y. S. Chen, M. D. Ang, C. Y. Yang, et al., “Proximal Fibular Osteotomy Relieves Pain in Spontaneous Osteonecrosis of the Knee: A Retrospective Study,” Medicine (Baltimore) 30 (2022): e29585.

[721] C. Fu, F. Wang, Y. Zhu, et al., “Severe Medial Osteoarthritis Predicts Patient Dissatisfaction After Proximal Fibular Osteotomy: A Mid- to Long-term Follow-up Study,” International Orthopaedics 1 (2024): 95–101.

[722] J. A. Sugianto, T. Hadipranata, G. Lazarus, et al., “Proximal Fibular Osteotomy for the Management of Medial Compartment Knee Osteoarthritis: A Systematic Review and Meta-analysis,” The Knee 28 (2021): 169–185.

[723] Y. Jiang, J. Li, L. Zhang, et al., “Clinical Efficacy and Radiological Changes of Proximal Fibular Osteotomy for Medial Compartment Knee Osteoarthritis: A Systematic Review and Meta-analysis,” Journal of Orthopaedic Surgery and Research 1 (2025): 672.

[724] X. T. Deng, H. Z. Hu, Z. Z. Wang, et al., “Comparison of Clinical and Radiological Outcomes between Upper Fibular Curvature and Non-Curvature With Medial Knee Osteoarthritis Following Proximal Fibular Osteotomy: A Retrospective Cohort Study With Minimum 2-Year Follow-up,” Orthop Surg 4 (2021): 1369–1377.

[725] R. S. Chien, C. P. Yang, C. R. Chaung, et al., “Functional and Radiographic Results of Arthroscopy-Assisted Lateral Open-Wedge Distal Femur Osteotomy for Lateral Compartment Osteoarthritis With Valgus Knee,” Journal of Clinical Medicine 1 (2022): 176.

[726] G. Ciolli, L. Proietti, M. Mercurio, et al., “Return to Sport Following Distal Femur Osteotomy: A Systematic Review,” Orthop Rev (Pavia) 2 (2022): 33774.

[727] K. P. Gunther, S. Deckert, C. Lutzner, et al., “Total Hip Replacement for Osteoarthritis-Evidence-Based and Patient-Oriented Indications,” Dtsch Arztebl Int 43 (2021): 730–736.

[728] E. Zaballa, E. Dennison, and K. Walker-Bone, “Function and Employment After Total Hip Replacement in Older Adults: A Narrative Review,” Maturitas 167 (2023): 8–16.

[729] O. E. Svinoy, J. V. Nordbo, A. H. Pripp, et al., “The Effect of Prehabilitation for Older Patients Awaiting Total Hip Replacement. A Randomized Controlled Trial With Long-term Follow up,” BMC Musculoskeletal Disorders [Electronic Resource] 1 (2025): 227.

[730] J. Juhlin, N. Sernert, and K. Ahlund, “Pre-operative Gluteus Medius Tendon Degeneration and Its Impact on Strength and Functional Ability One Year After Total Hip Replacement,” Annals of Medicine 1 (2024): 2388701.

[731] L. Perronne, O. Haehnel, S. Chevret, et al., “How Is Quality of Life After Total Hip Replacement Related to the Reconstructed Anatomy? A Study With Low-dose Stereoradiography,” Diagn Interv Imaging 2 (2021): 101–107.

[732] P. A. Slullitel, M. M. Mahatma, M. Farzi, et al., “Influence of Femoral Component Design on Proximal Femoral Bone Mass after Total Hip Replacement: A Randomized Controlled Trial,” Journal of Bone and Joint Surgery American Volume 1 (2021): 74–83.

[733] J. Vosahlo, A. Salus, M. Smolko, et al., “Oral Enzyme Combination With Bromelain, Trypsin and the Flavonoid Rutoside Reduces Systemic Inflammation and Pain When Used Pre- and Post-operatively in Elective Total Hip Replacement: A Randomized Exploratory Placebo-controlled Trial,” Ther Adv Musculoskelet Dis 15 (2023): 1759720×231186875.

[734] V. Dudoniene, A. Adomaityte, and L. Zlibinaite, “Randomized Controlled Trial to Compare Conventional Physiotherapy With Task-oriented Exercises After Total Hip Replacement,” J Back Musculoskelet Rehabil 4 (2023): 947–955.

[735] A. M. Rooney, D. W. Dempster, J. W. Nieves, et al., “Effects of Teriparatide and Loading Modality on Modeling-based and Remodeling-based Bone Formation in the human Femoral Neck,” Bone (New York) 157 (2022): 116342.

[736] K. Xia, L. Min, W. Xie, et al., “Is Unicompartmental Knee Arthroplasty a Better Choice Than Total Knee Arthroplasty for Unicompartmental Osteoarthritis? A Systematic Review and Meta-analysis of Randomized Controlled Trials,” Chin Med J (Engl) 13 (2025): 1568–1577.

[737] G. M. Orange, D. A. Hince, M. J. Travers, et al., “Physical Function Following Total Knee Arthroplasty for Osteoarthritis: A Longitudinal Systematic Review with Meta-analysis,” Journal of Orthopaedic and Sports Physical Therapy 1 (2025): 1–11.

[738] A. M. Swamy, R. Malhotra, V. Digge, et al., “Accelerometer-based Portable Navigation, a Faster Guide Compared to Computer-assisted Navigation in Bilateral Total Knee Arthroplasty-a Randomized Controlled Study,” Knee Surgery, Sports Traumatology, Arthroscopy 3 (2023): 786–792.

[739] P. Bollars, D. Janssen, W. De Weerdt, et al., “Improved Accuracy of Implant Placement With an Imageless Handheld Robotic System Compared to Conventional Instrumentation in Patients Undergoing Total Knee Arthroplasty: A Prospective Randomized Controlled Trial Using CT-based Assessment of Radiological Outcomes,” Knee Surgery, Sports Traumatology, Arthroscopy 12 (2023): 5446–5452.

[740] W. Beel, E. Sappey-Marinier, R. Latifi, et al., “Individualised Compared to off-the-shelf Total Knee Arthroplasty Results in Lower and Less Variable Patellar Tilt,” Knee Surgery, Sports Traumatology, Arthroscopy 12 (2024): 3163–3173.

[741] E. T. Petersen, S. Rytter, D. Koppens, et al., “Medial Congruent Polyethylene Design Show Different Tibiofemoral Kinematics and Enhanced Congruency Compared to a Standard Symmetrical Cruciate Retaining Design for Total Knee Arthroplasty-an in Vivo Randomized Controlled Study of Gait Using Dynamic Radiostereometry,” Knee Surgery, Sports Traumatology, Arthroscopy 3 (2023): 933–945.

[742] W. Gan, J. Ouyang, G. She, et al., “ChatGPT's Role in Alleviating Anxiety in Total Knee Arthroplasty Consent Process: A Randomized Controlled Trial Pilot Study,” Int J Surg 3 (2025): 2546–2557.

[743] U. Olsen, M. F. Lindberg, C. Rose, et al., “Factors Correlated with Physical Function 1 Year after Total Knee Arthroplasty in Patients with Knee Osteoarthritis: A Systematic Review and Meta-analysis,” JAMA Network Open 7 (2022): e2219636.

[744] J. Lutzner, F. Beyer, C. Lutzner, et al., “Increased Inflammatory Response Is Associated With Less Favorable Functional Results 5 Years After Total Knee Arthroplasty,” Knee Surgery, Sports Traumatology, Arthroscopy 4 (2023): 1316–1322.

Rights & permissions

2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.